{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:09:46Z","timestamp":1792159786015,"version":"4.4.0"},"reference-count":670,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience &amp; Biobehavioral Reviews"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.neubiorev.2022.104541","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T13:13:43Z","timestamp":1642598023000},"page":"104541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["The three sisters of fate: Genetics, pathophysiology and outcomes of animal models of neurodegenerative diseases"],"prefix":"10.1016","volume":"135","author":[{"given":"Michael","family":"Klonarakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"De Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8356-1214","authenticated-orcid":false,"given":"Emma K.","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5199-2666","authenticated-orcid":false,"given":"Liam T.","family":"Ralph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"Thacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4982-1662","authenticated-orcid":false,"given":"Joana","family":"Gil-Mohapel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neubiorev.2022.104541_bib0005","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/brain\/awn312","article-title":"Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies","volume":"132","author":"Adalbert","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0010","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2202-9-28","article-title":"Development of transgenic rats producing human beta-amyloid precursor protein as a model for Alzheimer's disease: transgene and endogenous APP genes are regulated tissue-specifically","volume":"9","author":"Agca","year":"2008","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0015","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1523\/JNEUROSCI.1230-20.2020","article-title":"Associations between Vascular Function and Tau PET Are Associated with Global Cognition and Amyloid","volume":"40","author":"Albrecht","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0020","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1006\/exnr.1998.6842","article-title":"Metabolic compromise with systemic 3-nitropropionic acid produces striatal apoptosis in Sprague\u2013Dawley rats but not in BALB\/c ByJ mice","volume":"153","author":"Alexi","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0025","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0014-2999(86)90573-X","article-title":"1-Methyl-4-phenylpyridine (MPP+): regional dopamine neuron uptake, toxicity, and novel rotational behavior following dopamine receptor proliferation","volume":"131","author":"Altar","year":"1986","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0030","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.expneurol.2007.10.012","article-title":"Characterization of the striatal 6-OHDA model of Parkinson\u2019s disease in wild type and \u03b1-synuclein-deleted mice","volume":"210","author":"Alvarez-Fischer","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0035","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of Ser-129 is the dominant pathological modification of \u03b1-synuclein in familial and sporadic lewy body disease","volume":"281","author":"Anderson","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0040","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.expneurol.2007.05.010","article-title":"Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson\u2019s disease","volume":"207","author":"Anderson","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0045","doi-asserted-by":"crossref","first-page":"8198","DOI":"10.1523\/JNEUROSCI.21-20-08198.2001","article-title":"Age-dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice","volume":"21","author":"Andreasson","year":"2001","journal-title":"J.Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0050","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0703219104","article-title":"DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase","volume":"104","author":"Andres-Mateos","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0055","doi-asserted-by":"crossref","first-page":"15846","DOI":"10.1523\/JNEUROSCI.4357-09.2009","article-title":"Unexpected lack of hypersensitivity in LRRK2 knock-out mice to MPTP (1-Methyl-4-Phenyl-1,2,3,6-tetrahydropyridine)","volume":"29","author":"Andres-Mateos","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0060","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1089\/10445490152717604","article-title":"Behavioral assessment of Alzheimer's transgenic mice following long-term Abeta vaccination: task specificity and correlations between Abeta deposition and spatial memory. Biol","volume":"20","author":"Arendash","year":"2001","journal-title":"DNA Cell"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/683920","article-title":"Neuroprotective function of DJ-1 in Parkinson\u2019s disease","volume":"2013","author":"Ariga","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0070","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3389\/fnagi.2019.00320","article-title":"Role of tau protein in remodeling of circadian neuronal circuits and sleep","volume":"11","author":"Arnes","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0075","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death","volume":"431","author":"Arrasate","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0080","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ana.20904","article-title":"Pesticide exposure and risk for Parkinson\u2019s disease","volume":"60","author":"Ascherio","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0085","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00221-011-2861-2","article-title":"Functions of the APP gene family in the nervous system: insights from mouse models","volume":"217","author":"Aydin","year":"2012","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0090","first-page":"152","article-title":"Aggregation of a-Synuclein in lewy bodies of sporadic Parkinson\u2019s disease and dementia with lewy bodies","author":"Baba","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0095","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.3233\/JAD-2010-100675","article-title":"Cognitive deficits associated with alteration of synaptic metaplasticity precede plaque deposition in a beta PP23 transgenic mice experimental models for neurodegenerative diseases view project antibody-mediated clearance mechanisms in the brain view proj","volume":"21","author":"Balducci","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0100","doi-asserted-by":"crossref","first-page":"15233","DOI":"10.1073\/pnas.96.26.15233","article-title":"Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer\u2019s disease","volume":"96","author":"Bales","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0105","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1523\/JNEUROSCI.0887-09.2009","article-title":"Human APOE isoform-dependent effects on brain beta-amyloid levels in PDAPP transgenic mice","volume":"29","author":"Bales","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0110","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.parkreldis.2010.11.008","article-title":"Genetic characteristics of leucine-rich repeat kinase 2 (LRRK2) associated Parkinson\u2019s disease","volume":"17","author":"Bardien","year":"2011","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0115","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/prca.201300099","article-title":"The pig as an animal model for human pathologies: a proteomics perspective","volume":"8","author":"Bassols","year":"2014","journal-title":"Proteomics - Clin. Appl."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0120","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1471-4159.2005.03169.x","article-title":"Regional and subtype selective changes of neurotransmitter receptor density in a rat transgenic for the Huntington\u2019s disease mutation","volume":"94","author":"Bauer","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0125","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3233\/JHD-130001","article-title":"A transgenic minipig model of Huntington\u2019s Disease","volume":"2","author":"Baxa","year":"2013","journal-title":"J. Huntingtons Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0130","article-title":"Longitudinal study revealing motor, cognitive and behavioral decline in a transgenic minipig model of Huntington\u2019s disease","volume":"13","author":"Baxa","year":"2019","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2020.101903","article-title":"Bilateral striatal transplantation of human olfactory stem cells ameliorates motor function, prevents necroptosis-induced cell death and improves striatal volume in the rat model of Huntington\u2019s disease","volume":"112","author":"Bayat","year":"2021","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0140","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1523\/JNEUROSCI.11-06-01649.1991","article-title":"Chronic quinolinic acid lesions in rats closely resemble Huntington\u2019s disease","volume":"11","author":"Beal","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0145","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1523\/JNEUROSCI.11-01-00147.1991","article-title":"Neurochemical characterization of excitotoxin lesions in the cerebral cortex","volume":"11","author":"Beal","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0150","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1471-4159.1993.tb03633.x","article-title":"Age\u2010dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate","volume":"61","author":"Beal","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0155","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","article-title":"Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid","volume":"13","author":"Beal","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0160","doi-asserted-by":"crossref","first-page":"46907","DOI":"10.1074\/jbc.M409544200","article-title":"Reduced \u03b2-Amyloid production and increased inflammatory responses in presenilin conditional knock-out mice","volume":"279","author":"Beglopoulos","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0165","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.nbd.2007.06.008","article-title":"Abnormal processing of tau in the brain of aged TgCRND8 mice","volume":"27","author":"Bellucci","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0170","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/j.1582-4934.2009.00781.x","article-title":"The rat as an animal model of Alzheimer\u2019s disease","volume":"13","author":"Benedikz","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0175","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.neuroscience.2007.03.010","article-title":"Glutamate receptor abnormalities in the YAC128 transgenic mouse model of Huntington\u2019s disease","volume":"147","author":"Benn","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0180","doi-asserted-by":"crossref","first-page":"E1289","DOI":"10.1073\/pnas.1710329115","article-title":"Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease","volume":"115","author":"Bennett","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0185","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.4103\/1673-5374.262571","article-title":"Physiological and pathological effects of amyloid-\u03b2 species in neural stem cell biology","volume":"14","author":"Bernabeu-Zornoza","year":"2019","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0190","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.phrs.2003.11.018","article-title":"The current status of Alzheimer\u2019s disease genetics: what do we tell the patients?","volume":"50","author":"Bertram","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0195","first-page":"1657","article-title":"Evidence for genetic linkage of Alzheimer\u2019s disease to chromosome 10q downloaded from","volume":"20","author":"Bertram","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0200","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039953","article-title":"Overexpression of parkin ameliorates dopaminergic neurodegeneration induced by 1- methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice","volume":"7","author":"Bian","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0210","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.nbd.2017.08.005","article-title":"Recent findings on the physiological function of DJ-1: beyond Parkinson\u2019s disease","volume":"108","author":"Biosa","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0215","doi-asserted-by":"crossref","first-page":"43245","DOI":"10.1074\/jbc.M305057200","article-title":"In vivo calpain\/caspase cross-talk during 3-nitropropionic acid-induced striatal degeneration: implication of a calpain-mediated cleavage of active caspase-3","volume":"278","author":"Bizat","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0220","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/hmg\/ddl094","article-title":"Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6\/2 transgenic mouse model of Huntington\u2019s disease","volume":"15","author":"Bjorkqvist","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0225","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00702-017-1715-x","article-title":"The use of nonhuman primate models to understand processes in Parkinson\u2019s disease","volume":"125","author":"Blesa","year":"2018","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0230","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brainres.2004.01.021","article-title":"Early exploratory behavior abnormalities in R6\/1 Huntington\u2019s disease transgenic mice","volume":"1005","author":"Bolivar","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0235","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/s41593-020-0691-x","article-title":"First, tau causes NO problem","volume":"23","author":"Bonnar","year":"2020","journal-title":"Nat Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0240","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.neurobiolaging.2004.06.010","article-title":"Neocortical synaptic bouton number is maintained despite robust amyloid deposition in APP23 transgenic mice","volume":"26","author":"Boncristiano","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0245","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.molbrainres.2004.11.005","article-title":"Redox cycling of the herbicide paraquat in microglial cultures","volume":"134","author":"Bonneh-Barkay","year":"2005","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0250","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0006-8993(95)00901-2","article-title":"Behavioral pathology induced by repeated systemic injections of 3-nitropropionic acid mimics the motoric symptoms of Huntington\u2019s disease","volume":"697","author":"Borlongan","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0255","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bbr.2008.05.008","article-title":"Middle-aged human apoE4 targeted-replacement mice show retention deficits on a wide range of spatial memory tasks","volume":"193","author":"Bour","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0260","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neuroscience.2011.10.057","article-title":"Neurotoxin-based models of Parkinson\u2019s disease","volume":"211","author":"Bov\u00e9","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0265","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1602\/neurorx.2.3.484","article-title":"Toxin-induced models of Parkinson\u2019s disease","volume":"2","author":"Bov\u00e9","year":"2005","journal-title":"NeuroRX"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0270","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/0006-2952(84)90344-7","article-title":"Repeated administration of N-methyl-4-phenyl 1,2,5,6-tetrahydropyridine to rats is not toxic to striatal dopamine neurones","volume":"33","author":"Boyce","year":"1984","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0275","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0280","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0285","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1002\/jnr.21642","article-title":"Nonmotor symptoms in Parkinson\u2019s disease: investigating early\u2010phase onset of behavioral dysfunction in the 6\u2010hydroxydopamine\u2010lesioned rat model","volume":"86","author":"Branchi","year":"2008","journal-title":"J. Neurosci. Res."},{"issue":"7","key":"10.1016\/j.neubiorev.2022.104541_bib0290","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1750-1326-7-58","article-title":"The isotropic fractionator provides evidence for differential loss of hippocampal neurons in two mouse models of Alzheimer\u2019s disease","volume":"22","author":"Brautigam","year":"2012","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0295","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1007\/s12035-014-8911-6","article-title":"A genetic mouse model of Parkinson\u2019s disease shows involuntary movements and increased postsynaptic sensitivity to apomorphine","volume":"52","author":"Brehm","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0300","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1111\/j.1471-4159.1985.tb07192.x","article-title":"Regional mitochondrial respiratory activity in Huntington\u2019s disease brain","volume":"44","author":"Brennan","year":"1985","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108045","article-title":"Fyn kinase controls tau aggregation in vivo","volume":"32","author":"Briner","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0310","first-page":"89","article-title":"Neurofibrillary tangles of Alzheimer\u2019s disease: an immunohistochemical study","volume":"17","author":"Brion","year":"1985","journal-title":"J. Submicrosc. Cytol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0315","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrn2652","article-title":"Tests to assess motor phenotype in mice: a user\u2019s guide","volume":"10","author":"Brooks","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(98)01192-5","article-title":"Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss","volume":"823","author":"Brooks","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0325","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1471-4159.1993.tb05859.x","article-title":"Age\u2010dependent vulnerability of the striatum to the mitochondrial toxin 3\u2010Nitropropionic acid","volume":"60","author":"Brouillet","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0330","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1073\/pnas.92.15.7105","article-title":"Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates","volume":"92","author":"Brouillet","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0335","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1046\/j.1471-4159.1998.70020794.x","article-title":"Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat","volume":"70","author":"Brouillet","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0340","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.1471-4159.2005.03515.x","article-title":"3-nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington\u2019s disease","volume":"95","author":"Brouillet","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0345","doi-asserted-by":"crossref","first-page":"b158","DOI":"10.1136\/bmj.b158","article-title":"Alzheimer\u2019s disease","volume":"338","author":"Burns","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0350","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","article-title":"A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"80","author":"Burns","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0355","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1523\/JNEUROSCI.19-12-04867.1999","article-title":"Expression of human apolipoprotein E3 or E4 in the brains of apoe(-\/-) mice: isoform-specific effects on neurodegeneration","volume":"19","author":"Buttini","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0360","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/85064","article-title":"BACE1 is the major \u03b2-secretase for generation of A\u03b2 peptides by neurons","volume":"4","author":"Cai","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0365","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/27351","article-title":"Neuron loss in APP transgenic mice","volume":"395","author":"Calhoun","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0370","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0006-8993(95)00136-E","article-title":"Accumulation of amyloid precursor protein-like immunoreactivity in rat brain in response to thiamine deficiency","volume":"677","author":"Calingasan","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0375","first-page":"1063","article-title":"Novel neuritic clusters with accumulations of amyloid precursor protein and amyloid precursor-like protein 2 immunoreactivity in brain regions damaged by thiamine deficiency","volume":"149","author":"Calingasan","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0380","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3233\/JAD-2010-100285","article-title":"Tau protein role in sleep-wake cycle","volume":"21","author":"Cantero","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0385","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bbr.2006.02.028","article-title":"Progressive deterioration of reaction time performance and choreiform symptoms in a new Huntington\u2019s disease transgenic ratmodel","volume":"170","author":"Cao","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0390","doi-asserted-by":"crossref","first-page":"6826","DOI":"10.1073\/pnas.97.12.6826","article-title":"Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice","volume":"97","author":"Capsoni","year":"2000","journal-title":"J. Neurosci. Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0395","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/mcne.2002.1163","article-title":"Amyloid plaques in a model for sporadic Alzheimer\u2019s disease based on transgenic anti-nerve growth factor antibodies","volume":"21","author":"Capsoni","year":"2002","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0400","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nrd.2018.133","article-title":"Therapeutic approaches to huntington disease: from the bench to the clinic","volume":"17","author":"Caron","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0405","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice transgenic for the human Huntington\u2019s disease mutation","volume":"19","author":"Carter","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0410","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.expneurol.2006.07.009","article-title":"NR2B-containing NMDA receptors promote the neurotoxic effects of 3-nitropropionic acid but not of rotenone in the striatum","volume":"202","author":"Centonze","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0415","first-page":"525","volume":"539","author":"Cepeda","year":"2001"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0420","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3390\/ijms21010294","article-title":"L-DOPA in Parkinson\u2019s disease: looking at the \"False\" neurotransmitters and their meaning","volume":"21","author":"Chagraoui","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0425","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.nbd.2007.11.011","article-title":"Progressive behavioral deficits in DJ-1-deficient mice are associated with normal nigrostriatal function","volume":"29","author":"Chandran","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0430","doi-asserted-by":"crossref","DOI":"10.1126\/science.abb8255","article-title":"Tau: enabler of diverse brain disorders and target of rapidly evolving therapeutic strategies","volume":"371","author":"Chang","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0435","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/WAD.0b013e318199ff46","article-title":"Patterns of cerebral hypoperfusion in amnestic and dysexecutive MCI","volume":"23","author":"Chao","year":"2009","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0440","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/6374","article-title":"Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice","volume":"2","author":"Chapman","year":"1999","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0445","doi-asserted-by":"crossref","first-page":"21418","DOI":"10.1074\/jbc.M413955200","article-title":"Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice","volume":"280","author":"Chen","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0450","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/cdd.2012.42","article-title":"(G2019S) LRRK2 activates MKK4-JNK pathway and causes degeneration of SN dopaminergic neurons in a transgenic mouse model of PD","volume":"19","author":"Chen","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0455","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/nm1123","article-title":"Aggressive amyloidosis in mice expressing human amyloid peptides with the Arctic mutation","volume":"10","author":"Cheng","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0460","doi-asserted-by":"crossref","first-page":"23818","DOI":"10.1074\/jbc.M701078200","article-title":"Accelerating amyloid-fibrillization reduces oligomer levels and functional deficits in alzheimer disease mouse models","volume":"282","author":"Cheng","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0465","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s13311-012-0104-2","article-title":"A progressive mouse model of Parkinson\u2019s disease: the Thy1-aSyn (\u201cLine 61\u201d) mice","volume":"9","author":"Chesselet","year":"2012","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0470","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejphar.2017.03.023","article-title":"Simultaneous blockade of NMDA receptors and PARP-1 activity synergistically alleviate immunoexcitotoxicity and bioenergetics in 3-nitropropionic acid intoxicated mice: evidences from memantine and 3-aminobenzamide interventions","volume":"803","author":"Chidambaram","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0475","doi-asserted-by":"crossref","first-page":"21562","DOI":"10.1074\/jbc.M100710200","article-title":"Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695","volume":"276","author":"Chishti","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0480","first-page":"10","article-title":"Liposomal-formulated curcumin [Lipocurc\u2122] targeting HDAC (Histone Deacetylase) prevents apoptosis and improves motor deficits in Park 7 (DJ-1)-knockout rat model of Parkinson\u2019s disease: implications for epigenetics-based nanotechnology-driven drug platfor","author":"Chiu","year":"2013","journal-title":"J. Complement. Integr. Med."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0485","doi-asserted-by":"crossref","first-page":"15136","DOI":"10.1073\/pnas.0807581105","article-title":"Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat","volume":"105","author":"Choi","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0490","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.nbd.2006.08.021","article-title":"Age-associated increases of \u03b1-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson\u2019s disease?","volume":"25","author":"Chu","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0495","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/8438","article-title":"Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation","volume":"5","author":"Chui","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0500","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0733-8619(05)70228-0","article-title":"Neurobehavioral and neuropsychiatric symptoms in Alzheimer\u2019s disease: characteristics and treatment","volume":"18","author":"Chung","year":"2000","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0505","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.tips.2009.06.005","article-title":"Environmental toxins and Parkinson\u2019s disease: what have we learned from pesticide-induced animal models?","volume":"30","author":"Cicchetti","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0510","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1523\/JNEUROSCI.3672-12.2013","article-title":"Neurobiology of disease a transgenic alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric a, and Frank neuronal loss","volume":"33","author":"Cohen","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0173(98)00004-6","article-title":"The role of neuronal growth factors in neurodegenerative disorders of the human brain","volume":"27","author":"Connor","year":"1998","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0520","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1101\/lm.51002","article-title":"Overexpression of hAPPswe impairs rewarded alternation and contextual fear conditioning in a transgenic mouse model of Alzheimer\u2019s disease","volume":"9","author":"Corcoran","year":"2002","journal-title":"Learn. Mem."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0525","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/aje\/kwp006","article-title":"Parkinson\u2019s disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California","volume":"169","author":"Costello","year":"2009","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0530","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/263244a0","article-title":"Lesion of striatal neurons with kainic acid provides a model for Huntington\u2019s chorea","volume":"263","author":"Coyle","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0535","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.6338589","article-title":"Alzheimer's disease: a disorder of cortical cholinergic innervation","volume":"219","author":"Coyle","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0540","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/syn.20852","article-title":"Acute and long-term response of dopamine nigrostriatal synapses to a single, low-dose episode of 3-nitropropionic acid-mediated chemical hypoxia","volume":"65","author":"Crawford","year":"2011","journal-title":"Synapse"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0545","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000321984","article-title":"Apolipoprotein e E4 prevalence in Alzheimer\u2019s disease patients varies across global populations: a systematic literature review and meta-analysis","volume":"31","author":"Crean","year":"2011","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0550","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/mds.27296","article-title":"New developments in genetic rat models of Parkinson\u2019s disease","volume":"33","author":"Creed","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0555","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neulet.2004.05.057","article-title":"Effects of high cholesterol diet on gliosis in apolipoprotein e knockout mice: implications for Alzheimer\u2019s disease and stroke","volume":"369","author":"Crisby","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0560","doi-asserted-by":"crossref","DOI":"10.3791\/1376","article-title":"Murine model for Parkinson\u2019s disease: from 6-OH dopamine lesion to behavioral test","author":"da Concei\u00e7\u00e3o","year":"2010","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0565","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.nbd.2014.06.009","article-title":"Phenotypic characterization of recessive gene knockout rat models of Parkinson\u2019s disease","volume":"70","author":"Dave","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0570","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0575","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1002\/mds.22798","article-title":"The role of parkin in familial and sporadic Parkinson\u2019s disease","volume":"25","author":"Dawson","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0580","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0306-4522(98)00410-2","article-title":"Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the \u03b2-amyloid precursor protein","volume":"90","author":"Dawson","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0585","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1242\/jcs.114.6.1179","article-title":"Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice","volume":"114","author":"Dawson","year":"2001","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0590","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.neuroscience.2010.04.037","article-title":"Loss of tau elicits axonal degeneration in a mouse model of Alzheimer\u2019s disease","volume":"169","author":"Dawson","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0595","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41593-018-0236-8","article-title":"Animal models of neurodegenerative diseases","volume":"21","author":"Dawson","year":"2018","journal-title":"Nat. Neursosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0600","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1460-9568.2004.03586.x","article-title":"Attention and executive function deficits in chronic low-dose MPTP-treated non-human primates","volume":"20","author":"Decamp","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0605","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00005072-198809000-00003","article-title":"Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington\u2019s disease","volume":"47","author":"De La Monte","year":"1988","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0610","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jalz.2015.12.005","article-title":"Meta-analysis of synaptic pathology in Alzheimer\u2019s disease reveals selective molecular vesicular machinery vulnerability","volume":"12","author":"de Wilde","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0615","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.nbd.2011.12.013","article-title":"Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of \u03b1-synuclein in midbrain dopamine neurons","volume":"45","author":"Decressac","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0620","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1006\/neur.1996.0056","article-title":"Structural correlates of cognition in dementia: quantification and assessment of synapse change","volume":"5","author":"DeKosky","year":"1996","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0625","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.neuroscience.2007.03.024","article-title":"Exacerbation of excitotoxic neuronal death induced during mitochondrial inhibition in vivo: relation to energy imbalance or ATP depletion?","volume":"146","author":"Del R\u00edo","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0630","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1523\/JNEUROSCI.22-09-03445.2002","article-title":"Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice","volume":"22","author":"Dewachter","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0635","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neurobiolaging.2006.11.019","article-title":"Modulation of synaptic plasticity and Tau phosphorylation by wild-type and mutant presenilin1","volume":"29","author":"Dewachter","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0640","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1192\/bjp.116.532.255","article-title":"Socio-psychiatric consequences of Huntington\u2019s disease","volume":"116","author":"Dewhurst","year":"1970","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0645","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.freeradbiomed.2013.01.018","article-title":"Parkinson disease: from pathology to molecular disease mechanisms","volume":"62","author":"Dexter","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0650","doi-asserted-by":"crossref","first-page":"22768","DOI":"10.1074\/jbc.M200164200","article-title":"Accelerated plaque accumulation, associative learning deficits, and up-regulation of 7 nicotinic receptor protein in transgenic mice Co-expressing mutant human presenilin 1 and amyloid precursor proteins","volume":"277","author":"Dineley","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0655","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1750-1326-8-37","article-title":"Modeling Alzheimer\u2019s disease in transgenic rats","volume":"8","author":"Do Carmo","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0660","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1037\/0735-7044.113.5.982","article-title":"Behavioral disturbances in transgenic mice overexpressing the V717F B-amyloid precursor protein","volume":"113","author":"Dodart","year":"1999","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0665","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/00001756-200002280-00034","article-title":"Behavioral deficits in APP(V717F) transgenic mice deficient for the apolipoprotein E gene","volume":"11","author":"Dodart","year":"2000","journal-title":"Neuroreport"},{"issue":"3","key":"10.1016\/j.neubiorev.2022.104541_bib0670","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.conb.2007.04.010","article-title":"Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson\u2019s disease","volume":"17","author":"Dodson","year":"2007","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0675","doi-asserted-by":"crossref","first-page":"30797","DOI":"10.1074\/jbc.M505249200","article-title":"Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice","volume":"280","author":"Dominguez","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0680","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00401-016-1662-x","article-title":"Alzheimer\u2019s disease: experimental models and reality","volume":"133","author":"Drummond","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0685","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neurobiolaging.2003.08.008","article-title":"Inflammation occurs early during the A\u03b2 deposition process in TgCRND8 mice","volume":"25","author":"Dudal","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0690","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/383710a0","article-title":"Increased amyloid-\u03b242 (43) in brains of mice expressing mutant presenilin 1","volume":"383","author":"Duff","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0695","doi-asserted-by":"crossref","first-page":"15317","DOI":"10.1523\/JNEUROSCI.4026-09.2009","article-title":"ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo","volume":"29","author":"Dumanis","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0700","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1523\/JNEUROSCI.5092-10.2011","article-title":"A rat model of progressive nigral neurodegeneration induced by the Parkinson\u2019s disease-associated G2019S mutation in LRRK2","volume":"31","author":"Dusonchet","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0705","doi-asserted-by":"crossref","first-page":"13389","DOI":"10.1074\/jbc.M111571200","article-title":"Insulin-degrading enzyme rapidly removes the-amyloid precursor protein intracellular domain (AICD)","volume":"277","author":"Edbauer","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0710","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3233\/JAD-2004-6301","article-title":"Rat transgenic models with a phenotype of intracellular Abeta accumulation in hippocampus and cortex","volume":"6","author":"Echeverria","year":"2004","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0715","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.neuroscience.2004.07.036","article-title":"Altered mitogen-activated protein kinase signaling, tau hyperphosphorylation and mild spatial learning dysfunction in transgenic rats expressing the beta-amyloid peptide intracellularly in hippocampal and cortical neurons","volume":"129","author":"Echeverria","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0720","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0306-4522(86)90102-8","article-title":"Variability and functional recovery in the N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of parkinsonism in monkeys","volume":"18","author":"Eidelberg","year":"1986","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0725","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.915","article-title":"Early fine motor impairment and behavioral dysfunction in (Thy-1)-h[A30P] alpha-synuclein mice","volume":"8","author":"Ekmark-Lew\u00e9n","year":"2018","journal-title":"Brain Behav."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0730","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00429-009-0227-3","article-title":"Presenilin transgenic mice as models of Alzheimer\u2019s disease","volume":"214","author":"Elder","year":"2010","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0735","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/ilar.48.4.339","article-title":"Nonhuman primate models of Parkinson\u2019s disease","volume":"48","author":"Emborg","year":"2007","journal-title":"ILAR J."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0740","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/ana.23881","article-title":"Levodopa gains psychostimulant-like properties after nigral dopaminergic loss","volume":"74","author":"Engeln","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0745","first-page":"135","article-title":"Economic research on Alzheimer disease: a review of the literature","volume":"11","author":"Ernst","year":"1997","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0750","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neures.2020.12.002","article-title":"Transplantation of human dental pulp stem cells compensates for striatal atrophy and modulates neuro-inflammation in 3-nitropropionic acid rat model of Huntington\u2019s disease","volume":"170","author":"Eskandari","year":"2021","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0755","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/brain\/awl382","article-title":"Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain","volume":"130","author":"Eslamboli","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0760","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1001\/jama.1989.03430180093036","article-title":"Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported","volume":"262","author":"Evans","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0765","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1006\/exnr.1998.6818","article-title":"Evidence for normal aging of the septo-hippocampal cholinergic system in ApoE (-\/-) mice but impaired clearance of axonal degeneration products following injury","volume":"151","author":"Fagan","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0770","doi-asserted-by":"crossref","first-page":"S497","DOI":"10.1002\/mds.22028","article-title":"The history of dopamine and levodopa in the treatment of Parkinson\u2019sdisease","volume":"23","author":"Fahn","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0775","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neulet.2007.03.055","article-title":"Rosuvastatin reduces gliosis and the accelerated weight gain observed in WT and ApoE-\/- mice exposed to a high cholesterol diet","volume":"419","author":"Famer","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0780","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein e genotype and alzheimer disease: a meta-analysis","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0785","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1073\/pnas.0230450100","article-title":"Insulin-degrading enzyme regulates the levels of insulin, amyloid \u03b2-protein, and the \u03b2-amyloid precursor protein intracellular domain in vivo","volume":"100","author":"Farris","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0790","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-1-4939-7825-0_6","article-title":"Mouse models of Huntington\u2019s disease","volume":"1780","author":"Farshim","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0795","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.nbd.2004.07.001","article-title":"Alpha-synuclein and transgenic mouse models","volume":"17","author":"Fernagut","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0800","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1126\/science.2931802","article-title":"Selective sparing of a class of striatal neurons in Huntington\u2019s disease","volume":"230","author":"Ferrante","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0805","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0006-8993(87)90694-9","article-title":"Sparing of acetylcholinesterase-containing striatal neurons in Huntington\u2019s disease","volume":"411","author":"Ferrante","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0810","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1006\/exnr.1993.1006","article-title":"Excitotoxin lesions in primates as a model for Huntington\u2019s disease: histopathologic and neurochemical characterization","volume":"119","author":"Ferrante","year":"1993","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0815","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.neurobiolaging.2010.10.015","article-title":"First transgenic rat model developing progressive cortical neurofibrillary tangles","volume":"33","author":"Filipcik","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0820","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1038\/s41436-020-0917-z","article-title":"Frequency of the loss of CAA interruption in the HTT CAG tract and implications for Huntington disease in the reduced penetrance range","volume":"22","author":"Findlay Black","year":"2020","journal-title":"Genet. Med."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0825","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/329065a0","article-title":"Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor","volume":"329","author":"Fischer","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0830","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1037\/0735-7044.103.2.319","article-title":"Effects of intrahippocampal administration of colchicine on incentive contrast and on radial maze performance","volume":"103","author":"Flaherty","year":"1989","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0835","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.bbrc.2007.04.195","article-title":"A transgenic rat expressing human APP with the Swedish Alzheimer's disease mutation","volume":"358","author":"Folkesson","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0840","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1073\/pnas.0409713102","article-title":"Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and \u03b1-Synuclein","volume":"102","author":"Fornai","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0845","first-page":"600","article-title":"Similarities and differences between MPTP-induced parkinsonsim and Parkinson\u2019s disease. Neuropathologic considerations","volume":"60","author":"Forno","year":"1993","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0850","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1007\/s11064-021-03271-8","article-title":"A novel pharmacological protective role for safranal in an animal model of Huntington\u2019s disease","volume":"46","author":"Fotoohi","year":"2021","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0855","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1017\/S0033291700050054","article-title":"Conduct disorder and affective disorder among the offspring of patients with Huntington\u2019s disease","volume":"13","author":"Franz","year":"1983","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0860","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.170228","article-title":"The role of astrocytes in amyloid production and Alzheimer\u2019s disease","volume":"7","author":"Frost","year":"2017","journal-title":"Open Biol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0865","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/WNR.0b013e32818b2a0b","article-title":"14-3-3 proteins and protein phosphatases are not reduced in tau-deficient mice","volume":"18","author":"Fujio","year":"2007","journal-title":"Neuroreport"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0870","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1523\/JNEUROSCI.5170-04.2005","article-title":"Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model","volume":"25","author":"Fryer","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0875","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1016\/j.celrep.2018.02.042","article-title":"Directional reaching for water as a cortex-dependent behavioral framework for mice","volume":"22","author":"Gali\u00f1anes","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0880","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neubiorev.2019.04.002","article-title":"Depression in neurodegenerative diseases: common mechanisms and current treatment options","volume":"102","author":"Galts","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0885","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/373523a0","article-title":"Alzheimer-type neuropathology in transgenic mice overexpressing V717F \u03b2-amyloid precursor protein","volume":"373","author":"Games","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0890","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118947","article-title":"No dopamine cell loss or changes in cytoskeleton function in transgenic mice expressing physiological levels of wild type or G2019S mutant LRRK2 and in human fibroblasts","volume":"10","author":"Garcia-Miralles","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0895","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.cell.2019.06.036","article-title":"CAG repeat not polyglutamine length determines timing of Huntington\u2019s disease onset","volume":"178","author":"Genetic Modifiers of Huntington\u2019s Disease (GeM-HD) Consortium","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0900","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/BF01291788","article-title":"Animal models of Parkinson\u2019s disease: an empirical comparison with the phenomenology of the disease in man","volume":"103","author":"Gerlach","year":"1996","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0905","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.brainres.2014.06.011","article-title":"YAC128 Huntington\u2019s disease transgenic mice show enhanced short-term hippocampal synaptic plasticity early in the course of the disease","volume":"1581","author":"Ghilan","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0910","first-page":"S111","article-title":"Cerebral amyloid angiopathy and alzheimer\u2019s disease","volume":"61","author":"Ghiso","year":"2010","journal-title":"Hirosaki Med. J."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0915","first-page":"1174","article-title":"The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. I. An autosomal genome scan for genes that predispose to type 2 diabetes","volume":"67","author":"Ghosh","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0920","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","article-title":"Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein","volume":"34","author":"Giasson","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0925","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nature02426","article-title":"Genome sequence of the brown Norway rat yields insights into mammalian evolution","volume":"428","author":"Gibbs","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0930","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1111\/j.1460-9568.2008.06310.x","article-title":"Mechanisms of neurodegeneration in Huntington\u2019s disease","volume":"27","author":"Gil","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0935","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.brainresrev.2008.12.001","article-title":"The R6 lines of transgenic mice: a model for screening new therapies for Huntington\u2019s disease","volume":"59","author":"Gil","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0940","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2202-5-17","article-title":"Asialoerythropoetin is not effective in the R6\/2 line of Huntington\u2019s disease mice","volume":"5","author":"Gil","year":"2004","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0945","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.nbd.2005.05.006","article-title":"Reduced hippocampal neurogenesis in R6\/2 transgenic Huntington\u2019s disease mice","volume":"20","author":"Gil","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0950","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1755-5949.2011.00246.x","article-title":"Screening of therapeutic strategies for Huntington\u2019s disease in YAC128 transgenic mice","volume":"18","author":"Gil-Mohapel","year":"2012","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0955","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.brainres.2011.06.040","article-title":"Neurogenesis in Huntington\u2019s disease: can studying adult neurogenesis lead to the development of new therapeutic strategies?","volume":"1406","author":"Gil-Mohapel","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0960","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neurobiolaging.2018.01.020","article-title":"Locomotor differences in mice expressing wild-type human \u03b1-synuclein","volume":"65","author":"Giraldo","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0965","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1044-7431(03)00198-2","article-title":"Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation","volume":"24","author":"Gispert","year":"2003","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0970","doi-asserted-by":"crossref","first-page":"e5777","DOI":"10.1371\/journal.pone.0005777","article-title":"Parkinson Phenotype in Aged PINK1-Deficient Mice Is Accompanied by Progressive Mitochondrial Dysfunction in Absence of Neurodegeneration","volume":"4","author":"Gispert","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2022.104541_bib0975","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.expneurol.2012.01.002","article-title":"Pink1-deficiency in mice impairs gait, olfaction and serotonergic innervation of the olfactory bulb","volume":"235","author":"Glasl","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0980","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0985","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-3-7091-6842-4_7","article-title":"Mechanism of 6-hydroxydopamine neurotoxicity","volume":"50","author":"Glinka","year":"1997","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0990","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev-neuro-072116-031153","article-title":"Propagation of tau aggregates and neurodegeneration","volume":"40","author":"Goedert","year":"2017","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib0995","doi-asserted-by":"crossref","first-page":"8523","DOI":"10.1523\/JNEUROSCI.21-21-08523.2001","article-title":"Physiological and structural evidence for hippocampal involvement in persistent seizure susceptibility after traumatic brain injury","volume":"21","author":"Golarai","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1000","doi-asserted-by":"crossref","first-page":"43628","DOI":"10.1074\/jbc.M308947200","article-title":"Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons","volume":"278","author":"Goldberg","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1005","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.neuron.2005.01.041","article-title":"Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial parkinsonism-linked gene DJ-1","volume":"45","author":"Goldberg","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1010","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2741\/2128","article-title":"Pesticides and impairment of mitochondrial function in relation with the parkinsonian syndrome","volume":"12","author":"Gomez","year":"2007","journal-title":"Front. Biosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1015","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0197-4580(02)00091-X","article-title":"Motor dysfunction and gliosis with preserved dopaminergic markers in human \u03b1-synuclein A30P transgenic mice","volume":"24","author":"Gomez-Isla","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1020","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fendo.2020.00124","article-title":"Behavioral abnormalities in knockout and humanized tau mice","volume":"11","author":"Gon\u00e7alves","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-2006-9101","article-title":"Impaired brain glucose metabolism leads to Alzheimer neurofibrillary degeneration through a decrease in tau O-GlcNAcylation","volume":"9","author":"Gong","year":"2006","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-3940(95)12006-P","article-title":"Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice","volume":"199","author":"Gordon","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1035","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0197-4580(00)00249-9","article-title":"Correlation between cognitive deficits and A\u03b2 deposits in transgenic APP+PS1 mice","volume":"22","author":"Gordon","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1040","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/jnr.23625","article-title":"Evidence for early and progressive ultrasonic vocalization and oromotor deficits in a PINK1 gene knockout rat model of Parkinson\u2019s disease","volume":"93","author":"Grant","year":"2015","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1045","doi-asserted-by":"crossref","first-page":"E2634","DOI":"10.1073\/pnas.1713849115","article-title":"Identification of a highly neurotoxic \u03b1-synuclein species inducing mitochondrial damage and mitophagy in Parkinson\u2019s disease","volume":"115","author":"Grassi","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1050","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"Gray","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1055","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0197-4580(89)90143-7","article-title":"Excitatory amino acids and Alzheimer\u2019s disease","volume":"10","author":"Greenamyre","year":"1989","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1060","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1056\/NEJM2003ra020003","article-title":"Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"348","author":"Guttmacher","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1065","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0306-4522(96)00602-1","article-title":"Quantifiable bradykinesia, gait abnormalities and Huntington\u2019s disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid","volume":"79","author":"Guyot","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1070","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/molecules23010040","article-title":"Dopamine and levodopa prodrugs for the treatment of Parkinson\u2019s disease","volume":"23","author":"Haddad","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1075","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/mds.21413","article-title":"Olfactory loss may be a first sign of idiopathic Parkinson\u2019s disease","volume":"22","author":"Haehner","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1080","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.expneurol.2014.11.003","article-title":"Behavioural deficits in transgenic mice expressing human truncated (1\u2013120 amino acid) alpha-synuclein","volume":"264","author":"Hall","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1085","doi-asserted-by":"crossref","first-page":"20681","DOI":"10.1038\/srep20681","article-title":"Metabolic disruption identified in the Huntington\u2019s disease transgenic sheep model","volume":"6","author":"Handley","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1090","doi-asserted-by":"crossref","first-page":"E11293","DOI":"10.1073\/pnas.1711243115","article-title":"Brain urea increase is an early Huntington\u2019s disease pathogenic event observed in a prodromal transgenic sheep model and HD cases","volume":"114","author":"Handley","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1095","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1471-4159.2009.05869.x","article-title":"Rat tau proteome consists of six tau isoforms: implication for animal models of human tauopathies","volume":"108","author":"Hanes","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1100","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.201709069","article-title":"Microglia in Alzheimer\u2019s disease","volume":"217","author":"Hansen","year":"2018","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1105","doi-asserted-by":"crossref","first-page":"8727","DOI":"10.1073\/pnas.96.15.8727","article-title":"Transgenic mice expressing a Huntington\u2019s disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity","volume":"96","author":"Hansson","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1110","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/369488a0","article-title":"Altered microtubule organization in small-calibre axons of mice lacking tau protein","volume":"369","author":"Harada","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1115","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1120","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S1044-7431(03)00227-6","article-title":"BACE1 (beta-secretase) transgenic neurochernical deficits ind knockout mice: identification of and behavioral changes","volume":"24","author":"Harrison","year":"2003","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1125","doi-asserted-by":"crossref","first-page":"6213","DOI":"10.1523\/JNEUROSCI.0664-05.2005","article-title":"Treatment with an Amyloid-\u03b2 antibody ameliorates plaque load, learning deficits, and hippocampal long-term potentiation in a mouse model of Alzheimer\u2019s disease","volume":"25","author":"Hartman","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1130","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00702-017-1742-7","article-title":"Twenty years since the discovery of the parkin gene","volume":"124","author":"Hattori","year":"2017","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1135","doi-asserted-by":"crossref","first-page":"7951","DOI":"10.1523\/JNEUROSCI.20-21-07951.2000","article-title":"Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members","volume":"20","author":"Heber","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1140","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/archneur.60.8.1119","article-title":"Alzheimer disease in the US population: prevalence estimates using the 2000 census","volume":"60","author":"Hebert","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1145","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.0b013e31828726f5","article-title":"Alzheimer disease in the United States (2010-2050) estimated using the 2010 census","volume":"80","author":"Hebert","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1150","doi-asserted-by":"crossref","DOI":"10.1371\/currents.RRN1293","article-title":"Aspiration pneumonia and death in Huntington\u2019s disease","volume":"4","author":"Heemskerk","year":"2012","journal-title":"PLoS Curr."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1155","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1126\/science.6610213","article-title":"Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice","volume":"224","author":"Heikkila","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1160","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s004010051037","article-title":"Nerve cell loss in the thalamic mediodorsal nucleus in Huntington\u2019s disease","volume":"97","author":"Heinsen","year":"1999","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1165","doi-asserted-by":"crossref","first-page":"11872","DOI":"10.1073\/pnas.96.21.11872","article-title":"Presenilin 2 deficiency causes a mild pulmonary phenotype and No changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency","volume":"96","author":"Herreman","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1170","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1093\/hmg\/ddr348","article-title":"LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice","volume":"20","author":"Herzig","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1175","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000072863","article-title":"The use of transgenic and knock-in mice to study Huntington\u2019s disease","volume":"100","author":"Hickey","year":"2003","journal-title":"Cytogenet. Genome Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1180","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1750-1326-7-25","article-title":"LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors","volume":"7","author":"Hinkle","year":"2012","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1185","doi-asserted-by":"crossref","first-page":"101","DOI":"10.31887\/DCNS.2003.5.1\/hhippius","article-title":"The discovery of Alzheimer\u2019s disease","volume":"5","author":"Hippius","year":"2003","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1190","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1523\/JNEUROSCI.21-09-03017.2001","article-title":"Mitochondrial abnormalities in Alzheimer\u2019s disease","volume":"21","author":"Hirai","year":"2001","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.neubiorev.2022.104541_bib1195","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1750-1326-5-31","article-title":"BACE1-\/- mice exhibit seizure activity that does not correlate with sodium channel level or axonal localization","volume":"23","author":"Hitt","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1200","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0361-9230(03)00185-0","article-title":"Standardization and statistical approaches to therapeutic trials in the R6\/2 mouse","volume":"61","author":"Hockly","year":"2003","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1205","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41586-019-1506-7","article-title":"Conserved cell types with divergent features in human versus mouse cortex","volume":"573","author":"Hodge","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1210","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","article-title":"A YAC mouse model for Huntington\u2019s disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration","volume":"23","author":"Hodgson","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1215","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1471-4159.2003.01533.x","article-title":"Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats","volume":"84","author":"H\u00f6glinger","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1220","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nm0198-097","article-title":"Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes","volume":"4","author":"Holcomb","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1225","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1023\/A:1021691918517","article-title":"Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits","volume":"29","author":"Holcomb","year":"1999","journal-title":"Behav. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1230","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1073\/pnas.050004797","article-title":"Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease","volume":"97","author":"Holtzman","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1235","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.2174\/138161208784480171","article-title":"Cyclooxygenase-1 and-2 in the different stages of Alzheimer\u2019s disease pathology","volume":"14","author":"Hoozemans","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1240","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF03159971","article-title":"Oxidative energy metabolism in Alzheimer brain - Studies in early-onset and late-onset cases","volume":"16","author":"Hoyer","year":"1992","journal-title":"Mol. Chem. Neuropathol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1245","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.brainres.2006.10.085","article-title":"Neurodegeneration caused by expression of human truncated tau leads to progressive neurobehavioural impairment in transgenic rats","volume":"130","author":"Hrnkova","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1250","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","article-title":"Correlative memory deficits, AP3 elevation, and amyloid plaques in transgenic mice","volume":"274","author":"Hsiao","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1255","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1038\/nn1797","article-title":"Bace1 modulates myelination in the central and peripheral nervous system","volume":"9","author":"Hu","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1260","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1084\/jem.20171831","article-title":"BACE1 deletion in the adult mouse reverses preformed amyloid deposition and improves cognitive functions","volume":"215","author":"Hu","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1265","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0014-4886(03)00242-5","article-title":"Behavioral and neurochemical characterization of transgenic mice carrying the human presenilin-1 gene with or without the leucine-to-proline mutation at codon 235","volume":"183","author":"Huang","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1270","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3233\/JAD-170490","article-title":"Cognitive decline in preclinical Alzheimer\u2019s disease: amyloid-beta versus tauopathy","volume":"61","author":"Huber","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1275","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1523\/JNEUROSCI.3032-07.2008","article-title":"Smaller dendritic spines, weaker synaptic transmission, but enhanced spatial learningin mice lacking Shank1","volume":"28","author":"Hung","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1280","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1096\/fj.01-0732com","article-title":"Alterations in behavior, amyloid beta-42, caspase-3, and Cox-2 in mutant PS2 transgenic mouse model of Alzheimer's disease","volume":"16","author":"Hwang","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1285","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.brainres.2008.10.011","article-title":"Motor impairment and aberrant production of neurochemicals in human \u03b1-synuclein A30P+A53T transgenic mice with \u03b1-synuclein pathology","volume":"1250","author":"Ikeda","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1290","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0304-3940(99)00964-7","article-title":"Muscle weakness, hyperactivity, and impairment in fear conditioning in tau-deficient mice","volume":"279","author":"Ikegami","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1295","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.parkreldis.2017.07.027","article-title":"Promising rodent models in Parkinson\u2019s disease","volume":"46","author":"Imbriani","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1300","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1248\/bpb.34.92","article-title":"Parkinsonian rotenone mouse model: reevaluation of long-term administration of rotenone in C57BL\/6 mice","volume":"34","author":"Inden","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1305","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2174\/156720510793611592","article-title":"Tau in Alzheimer disease and related tauopathies","volume":"7","author":"Iqbal","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1310","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/00005072-199709000-00002","article-title":"APP(Sw) transgenic mice develop age-related a\u03b2 deposits and neuropil abnormalities, but No neuronal loss in CA1","volume":"56","author":"Irizarry","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1315","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/hmg\/ddg239","article-title":"Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse","volume":"12","author":"Itier","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1320","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuron.2018.06.003","article-title":"Dendritic tau in Alzheimer\u2019s disease","volume":"99","author":"Ittner","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1325","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1126\/science.1059946","article-title":"Metabolic regulation of brain A\u03b2 by neprilysin","volume":"292","author":"Iwata","year":"2001","journal-title":"Science (80-.)"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1330","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pharmthera.2005.03.010","article-title":"Metabolism of amyloid-\u03b2 peptide and Alzheimer\u2019s disease","volume":"108","author":"Iwata","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1335","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1073\/pnas.0600948103","article-title":"Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer\u2019s disease","volume":"103","author":"Jacobsen","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1340","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/hmg\/ddq063","article-title":"An ovine transgenic Huntington\u2019s disease model","volume":"10","author":"Jacobsen","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1345","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3389\/fnins.2015.00503","article-title":"Evaluation of models of Parkinson\u2019s disease","volume":"9","author":"Jagmag","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1350","doi-asserted-by":"crossref","first-page":"186","DOI":"10.5455\/jice.20140903012921","article-title":"Combination of lycopene, quercetin and poloxamer 188 alleviates anxiety and depression in 3-nitropropionic acid-induced Huntington\u2019s disease in rats","volume":"3","author":"Jain","year":"2014","journal-title":"J. Intercult. Ethnopharmacol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1355","doi-asserted-by":"crossref","first-page":"E4016","DOI":"10.1073\/pnas.1309143110","article-title":"Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model","volume":"110","author":"Janezic","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1360","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1385-299X(00)00018-0","article-title":"Analysis of the molecular heterogeneity of the microtubule-associated protein tau by two-dimensional electrophoresis and RT-PCR","volume":"5","author":"Janke","year":"2000","journal-title":"Brain Res. Brain Res. Protoc."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1365","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0197-4580(00)00107-X","article-title":"Spatial learning in transgenic mice expressing human presenilin 1 (PS1) transgenes","volume":"21","author":"Janus","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1370","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/35050110","article-title":"Amyloid-beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer\u2019s disease","volume":"408","author":"Janus","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1375","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1046\/j.1471-4159.1995.64020794.x","article-title":"Neurotoxic effect of intranigral injection of 1-methyl-4-phenylpyridinium on GABA-containing neurons and its relation to circling behavior","volume":"64","author":"Jasso-L\u00f3pez","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1380","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00702-015-1405-5","article-title":"Neuropathobiology of non-motor symptoms in Parkinson disease","volume":"122","author":"Jellinger","year":"2015","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1385","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/nn.4362","article-title":"Opportunities and challenges in modeling human brain disorders in transgenic primates","volume":"19","author":"Jennings","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1390","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1192\/bjp.163.6.790","article-title":"A study of psychiatric morbidity in patients with Huntington\u2019s disease, their relatives, and controls. Admissions to psychiatric hospitals in Denmark from 1969 to 1991","volume":"163","author":"Jensen","year":"1993","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1395","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.neuroscience.2003.08.007","article-title":"Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer\u2019s disease patients","volume":"122","author":"Ji","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1400","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00401-017-1788-5","article-title":"Parkinson\u2019s disease: experimental models and reality","volume":"135","author":"Jiang","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1405","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1242\/jcs.01558","article-title":"Tau phosphorylation in neuronal cell function and dysfunction","volume":"117","author":"Johnson","year":"2004","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1410","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1006\/nbdi.2002.0557","article-title":"Long-term potentiation is increased in the CA1 area of the Hippocampus of APPswe\/Ind CRND8 mice","volume":"11","author":"Jolas","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1415","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1523\/JNEUROSCI.5687-08.2009","article-title":"Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease","volume":"29","author":"Joshi","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1420","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1101\/lm.5.4.317","article-title":"Enhanced hippocampal CA1 LTP but normal spatial learning in inositol 1,4,5-trisphosphate 3-kinase(A)-deficient mice","volume":"5","author":"Jun","year":"1998","journal-title":"Learn. Mem."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1425","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10059-011-0077-8","article-title":"Pathway-specific alteration of synaptic plasticity in Tg2576 mice","volume":"32","author":"Jung","year":"2011","journal-title":"Mol. Cells"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1430","doi-asserted-by":"crossref","first-page":"6365","DOI":"10.1523\/JNEUROSCI.20-17-06365.2000","article-title":"Subcellular localization of wild-type and Parkinson\u2019s disease-associated mutant alpha -synuclein in human and transgenic mouse brain","volume":"20","author":"Kahle","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1435","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1440","doi-asserted-by":"crossref","first-page":"20119","DOI":"10.1038\/srep20119","article-title":"Interictal spikes during sleep are an early defect in the Tg2576 mouse model of \u03b2-amyloid neuropathology","volume":"6","author":"Kam","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1445","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/NEN.0b013e3181e4f733","article-title":"Stem cell quiescence in the hippocampal neurogenic niche is associated with elevated transforming growth factor-\u03b2 signaling in an animal model of Huntington","volume":"69","author":"Kandasamy","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1450","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.nbd.2005.12.014","article-title":"Selective striatal neuron loss and alterations in behavior correlate with impaired striatal function in Huntington\u2019s disease transgenic rats","volume":"22","author":"Kantor","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1455","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1073\/pnas.93.6.2317","article-title":"COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex","volume":"93","author":"Kaufmann","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1460","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0197-4580(02)00098-2","article-title":"Progressive age-related impairment of cognitive behavior in APP23 transgenic mice","volume":"24","author":"Kelly","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2017.12.002","article-title":"Characterization of early-onset motor deficits in the Pink1\u2212\/\u2212 mouse model of Parkinson disease","volume":"1680","author":"Kelm-Nelson","year":"2018","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1470","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad9704","article-title":"The BACE1 inhibitor verubecestat (MK-8931) reduces CNS b-Amyloid in animal models and in Alzheimer\u2019s disease patients","volume":"8","author":"Kennedy","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1475","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00401-020-02196-w","article-title":"The physiological roles of tau and a\u03b2: implications for Alzheimer\u2019s disease pathology and therapeutics","volume":"140","author":"Kent","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1480","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s10815-021-02106-3","article-title":"CAG repeat instability in embryonic stem cells and derivative spermatogenic cells of transgenic Huntington\u2019s disease monkey","volume":"38","author":"Khampang","year":"2021","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1485","first-page":"17","article-title":"Oxytocin prevents the development of 3-NP-Induced anxiety and depression in male and female rats: possible interaction of OXTR and mGluR2","author":"Khodagholi","year":"2020","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1490","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1073\/pnas.0501282102","article-title":"Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress","volume":"102","author":"Kim","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1495","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","article-title":"The role of apolipoprotein E in Alzheimer\u2019s disease","volume":"63","author":"Kim","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1500","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1523\/JNEUROSCI.4306-08.2009","article-title":"Enhanced NMDA receptor-mediated synaptic transmission, enhanced long-term potentiation, and impaired learning and memory in mice lacking IRSp53","volume":"29","author":"Kim","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1505","doi-asserted-by":"crossref","first-page":"8363","DOI":"10.3390\/ijms22168363","article-title":"New avenues for the treatment of Huntington\u2019s disease","volume":"22","author":"Kim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1510","doi-asserted-by":"crossref","first-page":"17401","DOI":"10.1523\/JNEUROSCI.3028-12.2012","article-title":"Beta amyloid-induced depression of hippocampal long-term potentiation is mediated through the amylin receptor","volume":"32","author":"Kimura","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1515","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1038\/d41586-018-05722-9","article-title":"The search for better animal models of Alzheimer\u2019s disease","volume":"559","author":"King","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1520","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1523\/JNEUROSCI.22-07-02780.2002","article-title":"Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system","volume":"22","author":"Kirik","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1525","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1073\/pnas.0536383100","article-title":"Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson\u2019s disease","volume":"100","author":"Kirik","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1530","doi-asserted-by":"crossref","first-page":"11441","DOI":"10.1073\/pnas.0702717104","article-title":"Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice","volume":"104","author":"Kitada","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1535","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1471-4159.2009.06152.x","article-title":"Impaired dopamine release and synaptic plasticity in the striatum of parkin\u2212\/\u2212 mice","volume":"110","author":"Kitada","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1540","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1152\/jn.2001.86.6.2667","article-title":"Electrophysiological and morphological changes in striatal spiny neurons in R6\/2 Huntington\u2019s disease transgenic mice","volume":"86","author":"Klapstein","year":"2001","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1545","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1089\/10430340252837206","article-title":"Dopaminergic cell loss induced by human A30P \u03b1 -Synuclein gene transfer to the rat substantia nigra","volume":"13","author":"Klein","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1550","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.neuroscience.2010.10.027","article-title":"Progressive loss of synaptic integrity in human apolipoprotein E4 targeted replacement mice and attenuation by apolipoprotein E2","volume":"171","author":"Klein","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1555","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1111\/j.1582-4934.2009.00809.x","article-title":"Cognitive impairment in the Tg6590 transgenic rat model of Alzheimer\u2019s disease","volume":"14","author":"Kloskowska","year":"2010","journal-title":"J. Cell. Mol. Med."},{"issue":"3","key":"10.1016\/j.neubiorev.2022.104541_bib1560","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1601-183X.2005.00124.x","article-title":"Behavioral phenotypes of amyloid-based genetically modified mouse models of Alzheimer\u2019s disease","volume":"4","author":"Kobayashi","year":"2005","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1565","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.3390\/molecules22101723","article-title":"BACE1 function and inhibition: implications of intervention in the amyloid pathway of Alzheimer\u2019s disease pathology","volume":"22","author":"Koelsch","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1570","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1750-1326-5-43","article-title":"Expression of human A53T alpha-synuclein in the rat substantia nigra using a novel AAV1\/2 vector produces a rapidly evolving pathology with protein aggregation, dystrophic neurite architecture and nigrostriatal degeneration with potential to model the pat","volume":"5","author":"Koprich","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1575","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167235","article-title":"Towards a non-human primate model of alpha-synucleinopathy for development of therapeutics for Parkinson\u2019s disease: optimization of AAV1\/2 delivery parameters to drive sustained expression of alpha synuclein and dopaminergic degeneration in Macaque","volume":"11","author":"Koprich","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1580","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0896-6273(89)90077-9","article-title":"Developmentally regulated expression of specific tau sequences","volume":"2","author":"Kosik","year":"1989","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1585","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1460-9568.2008.06329.x","article-title":"Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load","volume":"28","author":"Koson","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1590","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1097\/00001756-199411000-00009","article-title":"Intrastriatal 3-nitropropionic acid: a behavioral assessment","volume":"5","author":"Koutouzis","year":"1994","journal-title":"Neuroreport"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1595","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/mds.25292","article-title":"The current and projected economic burden of Parkinson\u2019s disease in the United States","volume":"28","author":"Kowal","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1600","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1531-8249(199912)46:6<842::AID-ANA6>3.0.CO;2-O","article-title":"Huntingtin aggregates may not predict neuronal death in Huntington\u2019s disease","volume":"46","author":"Kuemmerle","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1605","first-page":"35","article-title":"High-resolution PET studies in Alzheimer\u2019s disease","volume":"4","author":"Kumar","year":"1991","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1610","first-page":"274","article-title":"Colchicines-induced neurotoxicity as an animal model of sporadic dementia of Alzheimer\u2019s type","volume":"59","author":"Kumar","year":"2007","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a006320","article-title":"Animal models of Alzheimer disease","volume":"2","author":"LaFerla","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1620","doi-asserted-by":"crossref","first-page":"11693","DOI":"10.1523\/JNEUROSCI.2766-05.2005","article-title":"BACE1, a major determinant of selective vulnerability of the brain to Amyloid-\u03b2 amyloidogenesis, is essential for cognitive, emotional, and synaptic functions","volume":"25","author":"Laird","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1625","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0166-4328(02)00230-9","article-title":"Transgenic mice expressing the PS1-A246E mutation: effects on spatial learning, exploration, anxiety, and motor coordination","volume":"138","author":"Lalonde","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1630","first-page":"21","article-title":"Modification by apomorphine of the circling behaviour in the rat due to unilateral intranigral injection of 1-methyl-4-phenylpyridine (MPP+)","volume":"9","author":"Lange","year":"1989","journal-title":"J. Toxicol. Clin. Exp."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1635","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0014-2999(90)90152-V","article-title":"Behavioural effects and supersensitivity in the rat following intranigral MPTP and MPP+ administration","volume":"175","author":"Lange","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1640","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.3233\/JPD-179006","article-title":"The MPTP story","volume":"7","author":"Langston","year":"2017","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1645","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1037\/0735-7044.112.5.1199","article-title":"Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats","volume":"112","author":"Lannert","year":"1998","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1650","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0969-9961(03)00079-2","article-title":"Dendritic spine loss in the Hippocampus of young PDAPP and Tg2576 mice and its prevention by the ApoE2 genotype","volume":"13","author":"Lanz","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1655","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0006-8993(99)01698-4","article-title":"Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice","volume":"840","author":"Larson","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1660","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1750-3639.2003.tb00035.x","article-title":"Neuropathology and neurodegeneration in rodent brain induced by lentiviral vectormediated overexpression of \u03b1-Synuclein","volume":"13","author":"Lauwers","year":"2003","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1665","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.neurobiolaging.2005.12.005","article-title":"Non-invasive imaging of neuropathology in a rat model of \u03b1-synuclein overexpression","volume":"28","author":"Lauwers","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1670","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.nbd.2008.08.006","article-title":"Striosome-matrix pathology and motor deficits in the YAC128 mouse model of Huntington\u2019s disease","volume":"32","author":"Lawhorn","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1675","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/00001756-200404090-00014","article-title":"Decreased hippocampal cell proliferation in R6\/1 Huntington\u2019s mice","volume":"15","author":"Lazic","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1680","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1111\/j.1460-9568.2006.04715.x","article-title":"Neurogenesis in the R6\/1 transgenic mouse model of Huntington\u2019s disease: effects of environmental enrichment","volume":"23","author":"Lazic","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1685","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1086\/318207","article-title":"Wild-type huntingtin reduces the cellular toxicity of mutant huntingtin in vivo","volume":"68","author":"Leavitt","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1690","doi-asserted-by":"crossref","first-page":"84","DOI":"10.5607\/en.2013.22.2.84","article-title":"An update of animal models of alzheimer disease with a reevaluation of plaque depositions","volume":"22","author":"Lee","year":"2013","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1695","doi-asserted-by":"crossref","first-page":"8968","DOI":"10.1073\/pnas.132197599","article-title":"Human alpha-synuclein-harboring familial Parkinson\u2019s disease-linked Ala-53 --& Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice","volume":"99","author":"Lee","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1700","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.neurobiolaging.2014.07.011","article-title":"Behavioral, neurochemical, and pathologic alterations in bacterial artificial chromosome transgenic G2019S leucine-rich repeated kinase 2 rats","volume":"36","author":"Lee","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1705","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","article-title":"Parkinson\u2019s disease","volume":"373","author":"Lees","year":"2009","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1710","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1750-1326-9-29","article-title":"Motor and cognitive deficits in aged tau knockout mice in two background strains","volume":"9","author":"Lei","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1715","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1146\/annurev.neuro.31.060407.125547","article-title":"Descending pathways in motor control","volume":"1","author":"Lemon","year":"2008","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1720","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3233\/JAD-2010-1349","article-title":"A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment","volume":"20","author":"Leon","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1725","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neuroimage.2008.02.019","article-title":"Cortical thickness measured from MRI in the YAC128 mouse model of Huntington\u2019s disease","volume":"41","author":"Lerch","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1730","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neuroimage.2007.08.033","article-title":"Automated deformation analysis in the YAC128 Huntington disease mouse model","volume":"39","author":"Lerch","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1735","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1385\/JMN:29:3:215","article-title":"Role of DJ-1 in Parkinson\u2019s disease","volume":"29","author":"Lev","year":"2006","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1740","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.tins.2004.08.008","article-title":"Genetic mouse models of Huntington\u2019s and Parkinson\u2019s diseases: illuminating but imperfect","volume":"27","author":"Levine","year":"2004","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1745","doi-asserted-by":"crossref","first-page":"14940","DOI":"10.1073\/pnas.93.25.14940","article-title":"Assessment of normal and mutant human presenilin function in Caenorhabditis elegans","volume":"93","author":"Levitan","year":"1996","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1750","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/78078","article-title":"Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L)tau protein","volume":"25","author":"Lewis","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1755","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1126\/science.1058189","article-title":"Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP","volume":"293","author":"Lewis","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1760","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/7854_2013_246","article-title":"Large animal models of Huntington\u2019s disease","volume":"22","author":"Li","year":"2015","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1765","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1073\/pnas.93.12.6158","article-title":"Generation of mice with a 200-Kb amyloid precursor protein gene deletion by cre recombinase-mediated site-specific recombination in embryonic stem cells","volume":"93","author":"Li","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1770","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/hmg\/8.7.1227","article-title":"Ultrastructural localization and progressive formation of neuropil aggregates in Huntington\u2019s disease transgenic mice","volume":"8","author":"Li","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1775","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1602\/neurorx.2.3.447","article-title":"The use of the R6 transgenic mouse models of Huntington\u2019s disease in attempts to develop novel therapeutic strategies","volume":"2","author":"Li","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1780","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nn.2349","article-title":"Mutant LRRK2 R1441G BAC transgenic mice recapitulate cardinal features of Parkinson\u2019s disease","volume":"12","author":"Li","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1785","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1523\/JNEUROSCI.5604-09.2010","article-title":"Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson\u2019s disease mutation G2019S","volume":"30","author":"Li","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1790","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.2147\/DDDT.S58470","article-title":"Transgenic animal models for study of the pathogenesis of Huntington&rsquo;s disease and therapy","volume":"9","author":"Li","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1795","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.mcp.2016.11.001","article-title":"Genetics of Parkinson\u2019s disease","volume":"30","author":"Lill","year":"2016","journal-title":"Mol. Cell. Probes"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1800","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.bbadis.2008.10.005","article-title":"Genetic models of Parkinson disease","volume":"1792","author":"Lim","year":"2009","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1805","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/10.2.137","article-title":"Neurological abnormalities in a knock-in mouse model of Huntington\u2019s disease","volume":"10","author":"Lin","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1810","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.neuron.2009.11.006","article-title":"Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson\u2019s-disease-related mutant alpha-synuclein","volume":"64","author":"Lin","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1815","doi-asserted-by":"crossref","first-page":"9248","DOI":"10.1523\/JNEUROSCI.1731-12.2012","article-title":"Conditional expression of parkinson\u2019s disease-related mutant -synuclein in the midbrain dopaminergic neurons causes progressive neurodegeneration and degradation of transcription factor nuclear receptor related 1","volume":"32","author":"Lin","year":"2012","journal-title":"J. Neurosci."},{"issue":"Dec (23)","key":"10.1016\/j.neubiorev.2022.104541_bib1820","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1523\/JNEUROSCI.19-23-10428.1999","article-title":"Selective discrimination learning impairments in mice expressing the human Huntington\u2019s disease mutation","volume":"19","author":"Lione","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1825","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/cdd.2009.22","article-title":"Complex II inhibition by 3-NP causes mitochondrial fragmentation and neuronal cell death via an NMDA- and ROS-dependent pathway","volume":"16","author":"Liot","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1830","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.nbd.2008.03.005","article-title":"A transgenic rat that develops Alzheimer's disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment","volume":"31","author":"Liu","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1835","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.expneurol.2013.01.001","article-title":"Overexpression of parkin in the rat nigrostriatal dopamine system protects against methamphetamine neurotoxicity","volume":"247","author":"Liu","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1840","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1093\/hmg\/ddv249","article-title":"Selective expression of Parkinson\u2019s disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression","volume":"24","author":"Liu","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1845","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/jnr.24517","article-title":"Loss of Tau and fyn reduces compensatory effects of MAP2 for tau and reveals a fyn-independent effect of tau on calcium","volume":"97","author":"Liu","year":"2019","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1850","doi-asserted-by":"crossref","first-page":"10813","DOI":"10.1073\/pnas.152339799","article-title":"Alpha-synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson\u2019s disease","volume":"99","author":"Lo Bianco","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1855","doi-asserted-by":"crossref","first-page":"19877","DOI":"10.1038\/s41598-019-56329-7","article-title":"BACE1 partial deletion induces synaptic plasticity deficit in adult mice","volume":"29","author":"Lombardo","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1860","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/acel.12391","article-title":"Absence of Tau triggers age-dependent sciatic nerve morphofunctional deficits and motor impairment","volume":"15","author":"Lopes","year":"2016","journal-title":"Aging Cell"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1865","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fncel.2020.00006","article-title":"Unsuspected involvement of spinal cord in alzheimer disease","volume":"14","author":"Lorenzi","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1870","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1523\/JNEUROSCI.5351-08.2009","article-title":"Neurobiology of disease bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein","volume":"29","author":"Lu","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1875","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2011506118","article-title":"APPs\u03b1 rescues impaired Ca2+ homeostasis in APP- and APLP2-deficient hippocampal neurons","volume":"118","author":"Ludewig","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1880","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1017\/S0317167100032212","article-title":"3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin","volume":"18","author":"Ludolph","year":"1991","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1885","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0166-4328(01)00261-3","article-title":"Evaluation of R6\/2 HD transgenic mice for therapeutic studies in Huntington\u2019s disease: behavioral testing and impact of diabetes mellitus","volume":"126","author":"L\u00fcesse","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1890","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/S1353-8020(13)70022-1","article-title":"Modeling Lewy pathology propagation in Parkinson\u2019s disease","volume":"20","author":"Luk","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1895","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.20112457","article-title":"Intracerebral inoculation of pathological \u03b1-synuclein initiates a rapidly progressive neurodegenerative \u03b1-synucleinopathy in mice","volume":"209","author":"Luk","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1900","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fncel.2020.00247","article-title":"PHF-core tau as the potential initiating event for tau pathology in Alzheimer\u2019s disease","volume":"14","author":"Luna-Viramontes","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1905","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.expneurol.2007.04.007","article-title":"Chronic brain cytochrome oxidase inhibition selectively alters hippocampal cholinergic innervation and impairs memory: prevention by ladostigil","volume":"206","author":"Luques","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1910","doi-asserted-by":"crossref","first-page":"7319","DOI":"10.1073\/pnas.1701597114","article-title":"Poor caregiver mental health predicts mortality of patients with neurodegenerative disease","volume":"114","author":"Lwi","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1915","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1523\/JNEUROSCI.3439-13.2014","article-title":"Loss of MAP function leads to hippocampal synapse loss and deficits in the morris water maze with aging","volume":"34","author":"Ma","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1920","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000443665","article-title":"Mutated huntingtin causes testicular pathology in transgenic minipig boars","volume":"16","author":"Macakova","year":"2016","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1925","doi-asserted-by":"crossref","first-page":"e0217216","DOI":"10.1371\/journal.pone.0217216","article-title":"Trafficking of immune cells across the blood-brain barrier is modulated by neurofibrillary pathology in tauopathies","volume":"14","author":"Majerova","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1930","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0962-8924(98)01368-3","article-title":"Tau in Alzheimer\u2019s disease","volume":"8","author":"Mandelkow","year":"1998","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1935","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon I of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1940","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3389\/fphar.2019.00778","article-title":"Targeting synaptic plasticity in experimental models of Alzheimer\u2019s disease","volume":"10","author":"Mango","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1945","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1074\/jbc.C100560200","article-title":"The herbicide paraquat causes up-regulation and aggregation of \u03b1-Synuclein in mice","volume":"277","author":"Manning-Bog","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1950","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.nbd.2007.03.014","article-title":"Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter","volume":"27","author":"Manning-Bo\u011f","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1955","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0304-3940(87)90326-0","article-title":"Loss of hippocampal [3H]TCP binding in Alzheimer\u2019s disease","volume":"74","author":"Maragos","year":"1987","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1960","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.expneurol.2008.11.001","article-title":"Enhanced sensitivity to group II mGlu receptor activation at corticostriatal synapses in mice lacking the familial parkinsonism-linked genes PINK1 or Parkin","volume":"215","author":"Martella","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1965","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1755-5949.2010.00175.x","article-title":"Beyond the cholinergic hypothesis: do current drugs work in Alzheimer'sdisease?","volume":"16","author":"Martorana","year":"2010","journal-title":"CNS Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1970","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.nbd.2015.12.020","article-title":"Exposure to low-dose rotenone precipitates synaptic plasticity alterations in PINK1 heterozygous knockout mice","volume":"91","author":"Martella","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1975","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1089\/ars.2011.4033","article-title":"Toxin models of mitochondrial dysfunction in Parkinson\u2019s disease","volume":"16","author":"Martinez","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1980","article-title":"Cortical serotonergic and catecholaminergic denervation in MPTP-Treated parkinsonian monkeys","author":"Masilamoni","year":"2021","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1985","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/exnr.1995.1088","article-title":"Neurodegeneration in the central nervous system of ApoE-deficient mice","volume":"136","author":"Masliah","year":"1995","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib1990","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","article-title":"Dopaminergic loss and inclusion body formation in \u03b1-synuclein mice: implications for neurodegenerative disorders","volume":"287","author":"Masliah","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2022.104541_bib1995","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/jnen\/60.4.357","article-title":"Neurofibrillary pathology in transgenic mice overexpressing V717F \u03b2-amyloid precursor protein","volume":"60","author":"Masliah","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2000","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0028-3908(79)90149-7","article-title":"Kainic acid lesions of the striatum in rats mimic the spontaneous motor abnormalities of Huntington\u2019s disease","volume":"18","author":"Mason","year":"1979","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2005","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","article-title":"Amyloid plaque core protein in alzheimer disease and Down syndrome","volume":"82","author":"Masters","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2010","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1749-6632.1994.tb44401.x","article-title":"Calcium and neuronal injury in Alzheimer\u2019s disease: contributions of \u03b2\u2010Amyloid precursor protein mismetabolism, free radicals, and metabolic compromise","volume":"747","author":"Mattson","year":"1994","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2015","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1523\/JNEUROSCI.4129-14.2015","article-title":"The potent BACE1 inhibitor LY2886721 elicits robust central a\u03b2 pharmacodynamic responses in mice, dogs, and humans","volume":"35","author":"May","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2020","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009282","article-title":"Motor control abnormalities in Parkinson\u2019s disease","volume":"2","author":"Mazzoni","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2025","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1073\/pnas.0508875103","article-title":"Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington\u2019s disease","volume":"103","author":"McBride","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2030","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/nbdi.2002.0507","article-title":"Environmental risk factors and Parkinson\u2019s disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat","volume":"10","author":"McCormack","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2035","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/NEN.0b013e3181a24b53","article-title":"\u0391-synuclein S129 phosphorylation mutants do not alter nigrostriatal toxicity in a rat model of Parkinson disease","volume":"68","author":"McFarland","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2040","first-page":"258","article-title":"Duplication of biochemical changes of Huntington\u2019s chorea by intrastriatal injections of glutamic and kainic acids","volume":"13","author":"McGeer","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2045","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0165-0173(95)00011-9","article-title":"The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases","volume":"21","author":"McGeer","year":"1995","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS\u2010ADRDA work group under the auspices of department of health and human services task force","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2055","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ceb.2017.03.013","article-title":"PINK1 and Parkin: emerging themes in mitochondrial homeostasis","volume":"45","author":"McWilliams","year":"2017","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2060","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/cne.10295","article-title":"Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6\/2 transgenic mice","volume":"449","author":"Meade","year":"2002","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2065","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.nbd.2010.07.010","article-title":"Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice","volume":"40","author":"Melrose","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2070","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-1-4939-7825-0_6","article-title":"Mouse models of Huntington\u2019s disease","volume":"1780","author":"Menalled","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049838","article-title":"Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: ZQ175","volume":"7","author":"Menalled","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2080","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0896-6273(00)81109-5","article-title":"Neuroplasticity failure in Alzheimer\u2019s disease: bridging the gap between plaques and tangles","volume":"24","author":"Mesulam","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfm223","article-title":"Paraquat: the red herring of Parkinson\u2019s disease research","volume":"100","author":"Miller","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2090","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1113\/jphysiol.2007.142448","article-title":"Corticostriatal synaptic function in mouse models of Huntington\u2019s disease: early effects of huntingtin repeat length and protein load","volume":"585","author":"Milnerwood","year":"2007","journal-title":"J. Physiol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2095","article-title":"Brain Elderberry diet ameliorates motor function and prevents oxidative stress-induced cell death in rat models of Huntington disease","volume":"1762","author":"Moghaddam","year":"2021","journal-title":"Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2100","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s11064-009-9919-6","article-title":"Neprilysin deficiency-dependent impairment of cognitive functions in a mouse model of amyloidosis","volume":"34","author":"Mohajeri","year":"2009","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2105","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00702-003-0057-z","article-title":"Transgenic BACE expression in mouse neurons accelerates amyloid plaque pathology","volume":"111","author":"Mohajeri","year":"2004","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2110","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1002\/alz.12321","article-title":"Visualization of neurofibrillary tangle maturity in Alzheimer\u2019s disease: a clinicopathologic perspective for biomarker research","volume":"17","author":"Moloney","year":"2021","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","article-title":"APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline","volume":"581","author":"Montagne","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2120","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3233\/JHD-200429","article-title":"The contribution of somatic expansion of the CAG repeat to symptomatic development in Huntington\u2019s disease: a historical perspective","volume":"10","author":"Monckton","year":"2021","journal-title":"J. Huntingtons Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2125","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.theriogenology.2015.03.016","article-title":"Germline transmission in transgenic Huntington\u2019s disease monkeys","volume":"84","author":"Moran","year":"2015","journal-title":"Theriogenology"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2130","doi-asserted-by":"crossref","first-page":"24590","DOI":"10.18632\/oncotarget.25083","article-title":"Genome-wide significant risk factors on chromosome 19 and the APOE locus","volume":"9","author":"Moreno-Grau","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2135","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00702-017-1722-y","article-title":"Non-human primate models of PD to test novel therapies","volume":"125","author":"Morissette","year":"2018","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2140","first-page":"135","article-title":"Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer\u2019s disease","volume":"2","author":"Morris","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015752","article-title":"Executive decision-making in the domestic sheep","volume":"6","author":"Morton","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2150","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1023\/A:1010887421592","article-title":"Progressive formation of inclusions in the striatum and hippocampus of mice transgenic for the human Huntington\u2019s disease mutation","volume":"29","author":"Morton","year":"2000","journal-title":"J. Neurocytol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2155","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1523\/JNEUROSCI.3842-04.2005","article-title":"Disintegration of the sleep-wake cycle and circadian timing in Huntington\u2019s disease","volume":"25","author":"Morton","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2160","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1093\/hmg\/ddu047","article-title":"Early and progressive circadian abnormalities in Huntington\u2019s disease sheep are unmasked by social environment","volume":"23","author":"Morton","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2165","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41598-018-37102-8","article-title":"Antagonistic pleiotropy in mice carrying a CAG repeat expansion in the range causing Huntington\u2019s disease","volume":"9","author":"Morton","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2170","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1093\/brain\/awm208","article-title":"A new model to study compensatory mechanisms in MPTP-Treated monkeys exhibiting recovery","volume":"130","author":"Mounayar","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2175","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/mds.10473","article-title":"The unified Parkinson\u2019s disease rating scale (UPDRS): status and recommendations","volume":"18","author":"Movement Disorder Society Task Force on Rating Scales for Parkinson\u2019s Disease","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2180","first-page":"113","article-title":"Mechanisms of neuron loss in Alzheimer\u2019s disease","volume":"102","author":"Mukhin","year":"2016","journal-title":"Ross. Fiziol. Zh. Im. I. Sechenova"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2185","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bbr.2012.12.051","article-title":"The behavioural and neuropathological impact of intranigral AAV-\u03b1-synuclein is exacerbated by systemic infusion of the Parkinson\u2019s disease-associated pesticide, rotenone, in rats","volume":"243","author":"Mulcahy","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2190","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0092-8674(94)90066-3","article-title":"Behavioral and anatomical deficits in mice homozygous for a modified \u03b2-amyloid precursor protein gene","volume":"79","author":"M\u00fcller","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2195","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1523\/JNEUROSCI.20-13-05115.2000","article-title":"Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington\u2019s disease mutation","volume":"20","author":"Murphy","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2200","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0149-7634(05)80150-2","article-title":"Animal models of Alzheimer\u2019s disease: glutamatergic denervation as an alternative approach to cholinergic denervation","volume":"17","author":"Myhrer","year":"1993","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2205","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0091-3057(01)00634-7","article-title":"Involvement of microtubule integrity in memory impairment caused by colchicine","volume":"71","author":"Nakayama","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2210","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3390\/ijerph13090881","article-title":"Environmental exposures and Parkinson\u2019s disease","volume":"13","author":"Nandipati","year":"2016","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2215","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.lfs.2014.05.017","article-title":"Animal models of dementia and cognitive dysfunction","volume":"109","author":"Neha","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2220","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of alzheimer disease neuropathologic changes with cognitive status: a review of the literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2225","doi-asserted-by":"crossref","first-page":"e9316","DOI":"10.15252\/emmm.201809316","article-title":"The BACE \u20101 inhibitor CNP 520 for prevention trials in Alzheimer\u2019s disease","volume":"10","author":"Neumann","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2230","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/hmg\/ddx389","article-title":"G2019S LRRK2 enhances the neuronal transmission of tau in the mouse brain","volume":"27","author":"Nguyen","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2235","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0304-3940(94)90239-9","article-title":"\u03b2-Amyloid protein-induced Alzheimer\u2019s disease animal model","volume":"170","author":"Nitta","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2240","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1093\/hmg\/ddu748","article-title":"Early Parkinson\u2019s disease symptoms in -synuclein transgenic monkeys","volume":"24","author":"Niu","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2245","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/ana.23687","article-title":"Meta-analysis of early nonmotor features and risk factors for Parkinson disease","volume":"72","author":"Noyce","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2250","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1523\/JNEUROSCI.3040-07.2008","article-title":"Neurodegeneration and motor dysfunction in a conditional model of Parkinson\u2019s disease","volume":"28","author":"Nuber","year":"2008","journal-title":"J. Neurosci."},{"issue":"Oct 4 (40)","key":"10.1016\/j.neubiorev.2022.104541_bib2255","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2260","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.neurobiolaging.2003.08.012","article-title":"Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease","volume":"24","author":"Oddo","year":"2003","journal-title":"Neurobiol. Aging."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2265","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2270","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.neuron.2004.07.003","article-title":"Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome","volume":"43","author":"Oddo","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2275","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/jnc.13750","article-title":"Current and experimental treatments of Parkinson disease: a guide for neuroscientists","volume":"139","author":"Oertel","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2280","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0896-6273(03)00810-9","article-title":"BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer\u2019s disease","volume":"41","author":"Ohno","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2285","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1460-9568.2005.04551.x","article-title":"Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1","volume":"23","author":"Ohno","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2290","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1750-1326-8-44","article-title":"rAAV2\/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration","volume":"8","author":"Oliveras-Salv\u00e1","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2295","doi-asserted-by":"crossref","first-page":"411","DOI":"10.5604\/12321966.1232774","article-title":"Motor assessment in Parkinson\u0142s disease","volume":"24","author":"Opara","year":"2017","journal-title":"Ann. Agric. Environ. Med."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2300","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.53.9.1937","article-title":"Diabetes mellitus and the risk of dementia: the Rotterdam Study","volume":"53","author":"Ott","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2305","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao5620","article-title":"Axonal organization defects in the Hippocampus of adult conditional BACE1 knockout mice","volume":"10","author":"Ou-Yang","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2310","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3233\/JPD-130192","article-title":"LRRK2: cause, risk, and mechanism","volume":"3","author":"Pais\u00e1n-Ruiz","year":"2013","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2315","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1523\/JNEUROSCI.16-09-03019.1996","article-title":"Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington\u2019s disease","volume":"16","author":"Palfi","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2320","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.neuint.2009.04.013","article-title":"Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington\u2019s disease in rats","volume":"55","author":"Pandey","year":"2009","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2325","first-page":"555","article-title":"The contribution of the study of neurodegenerative disorders to the understanding of human memory","volume":"97","author":"Panegyres","year":"2004","journal-title":"QJM - Mon. J. Assoc. Phys."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2330","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington\u2019s disease are a direct effect of polyglutamines","volume":"5","author":"Panov","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2335","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/j.1460-9568.2005.04324.x","article-title":"Reduction of GnRH and infertility in the R6\/2 mouse model of Huntington\u2019s disease","volume":"22","author":"Papalexi","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2340","article-title":"Characterization of behavioral, neuropathological, brain metabolic and key molecular changes in zQ175 knock-in mouse model of Huntington\u2019s disease","volume":"11","author":"Peng","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2345","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1073\/pnas.0409598102","article-title":"Parkin-deficient mice are not a robust model of parkinsonism","volume":"102","author":"Perez","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2350","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/hmg\/ddi004","article-title":"Orexin loss in Huntington\u2019s disease","volume":"14","author":"Peters\u00e9n","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2355","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0896-6273(02)01125-X","article-title":"Parkin protects against the toxicity associated with mutant \u03b1-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons","volume":"36","author":"Petrucelli","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2360","doi-asserted-by":"crossref","first-page":"6363","DOI":"10.1038\/s41598-017-06724-9","article-title":"Early synaptic dysfunction induced by \u03b1-synuclein in a rat model of Parkinson\u2019s disease","volume":"7","author":"Phan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2365","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1073\/pnas.89.10.4471","article-title":"Generation of mice carrying a mutant apolipoprotein e gene inactivated by gene targeting in embryonic stem cells","volume":"89","author":"Piedrahita","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2370","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1523\/JNEUROSCI.1384-17.2017","article-title":"Lack of parkin anticipates the phenotype and affects mitochondrial morphology and mtDNA levels in a mouse model of Parkinson\u2019s disease","volume":"38","author":"Pinto","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2375","doi-asserted-by":"crossref","first-page":"10741","DOI":"10.1523\/JNEUROSCI.1065-09.2009","article-title":"Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology","volume":"29","author":"Polydoro","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2380","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2385","article-title":"Limitations of animal models of Parkinson\u2019s disease","volume":"2011","author":"Potashkin","year":"2010","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2390","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/brain\/awp006","article-title":"Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin","volume":"132","author":"Pouladi","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2395","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1093\/hmg\/ddq026","article-title":"Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression","volume":"19","author":"Pouladi","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2400","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1074\/jbc.M605066200","article-title":"Mutant presenilin 1 alters synaptic transmission in cultured hippocampal neurons","volume":"282","author":"Priller","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2405","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1517\/17460441.2015.1041913","article-title":"Rodent models for Alzheimer\u2019s disease drug discovery","volume":"10","author":"Puzzo","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2410","doi-asserted-by":"crossref","first-page":"10914","DOI":"10.1073\/pnas.95.18.10914","article-title":"Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females","volume":"95","author":"Raber","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2415","doi-asserted-by":"crossref","first-page":"317","DOI":"10.5114\/fn.2019.89857","article-title":"Rotenone: from modelling to implication in Parkinson\u2019s disease","volume":"57","author":"Radad","year":"2019","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2420","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jneuroim.2005.07.018","article-title":"High cholesterol diet results in increased expression of Interleukin-6 and Caspase-1 in the brain of apolipoprotein e knockout and wild type mice","volume":"169","author":"Rahman","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018568","article-title":"Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2","volume":"6","author":"Ramonet","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2430","doi-asserted-by":"crossref","first-page":"10637","DOI":"10.1523\/JNEUROSCI.3279-05.2005","article-title":"Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L)","volume":"25","author":"Ramsden","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2435","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/2510","article-title":"Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA","volume":"20","author":"Reddy","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2440","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1098\/rstb.1999.0456","article-title":"Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington\u2019s disease","volume":"354","author":"Reddy","year":"1999","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2445","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1742-2094-6-35","article-title":"Expression of complement system components during aging and amyloid deposition in APP transgenic mice","volume":"6","author":"Reichwald","year":"2009","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2450","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3233\/JHD-130067","article-title":"Further molecular characterisation of the OVT73 transgenic sheep model of Huntington\u2019s disease identifies cortical aggregates","volume":"2","author":"Reid","year":"2013","journal-title":"J. Huntingtons Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2455","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41467-019-14279-8","article-title":"Exceptionally low likelihood of alzheimer\u2019s dementia in APOE2 homozygotes from a 5,000-Person neuropathological study","volume":"11","author":"Reiman","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2460","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","article-title":"APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline","volume":"581","author":"Reiman","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2465","doi-asserted-by":"crossref","first-page":"10116","DOI":"10.1523\/JNEUROSCI.18-23-10116.1998","article-title":"Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington\u2019s disease","volume":"18","author":"Reynolds","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2470","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1111\/j.1460-9568.2004.03783.x","article-title":"Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington\u2019s disease mutation","volume":"20","author":"Ribchester","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2475","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/toxsci\/kfi304","article-title":"Paraquat neurotoxicity is distinct from that of MPTP and rotenone","volume":"88","author":"Richardson","year":"2005","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2480","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/exnr.2002.7882","article-title":"Behavioral and neurochemical effects of wild-type and mutated human \u03b1-synuclein in transgenic mice","volume":"175","author":"Richfield","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2485","volume":"14","author":"Rideout","year":"2017"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2490","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3233\/JHD-170284","article-title":"Vocalisation as a viable assessment for phenotyping minipigs transgenic for the huntington gene?","volume":"7","author":"Rieke","year":"2018","journal-title":"J. Huntingtons Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2495","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3233\/JHD-180325","article-title":"Activity behaviour of minipigs transgenic for the Huntington gene","volume":"8","author":"Rieke","year":"2019","journal-title":"J. Huntingtons Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2500","doi-asserted-by":"crossref","first-page":"7817","DOI":"10.1523\/JNEUROSCI.1026-07.2007","article-title":"The secreted \u03b2-amyloid precursor protein ectodomain APPs\u03b1 is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-deficient mice","volume":"27","author":"Ring","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2505","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/hmg\/10.12.1317","article-title":"BACE knockout mice are healthy despite lacking the primary \u03b2-secretase activity in brain: implications for Alzheimer\u2019s disease therapeutics","volume":"10","author":"Roberds","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2510","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1126\/science.1141736","article-title":"Reducing endogenous tau ameliorates amyloid \u03b2-Induced deficits in an Alzheimer\u2019s disease mouse model","volume":"316","author":"Roberson","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2515","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.neurobiolaging.2004.06.003","article-title":"apoE isoforms and measures of anxiety in probable AD patients and Apoe\u2212\/\u2212 mice","volume":"26","author":"Robertson","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2520","doi-asserted-by":"crossref","first-page":"28257","DOI":"10.1074\/jbc.270.47.28257","article-title":"Levels and alternative splicing of amyloid \u03b2 protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer\u2019s disease","volume":"270","author":"Rockenstein","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2525","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0306-4522(03)00381-6","article-title":"Electrophysiological studies on the Hippocampus and prefrontal cortex assessing the effects of amyloidosis in amyloid precursor protein 23 transgenic mice","volume":"120","author":"Roder","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2530","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1111\/j.1460-9568.2006.05060.x","article-title":"Persistent penetration of MPTP through the nasal route induces Parkinson\u2019s disease in mice","volume":"24","author":"Rojo","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2535","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13024-016-0140-1","article-title":"LRRK2 at the interface of autophagosomes, endosomes and lysosomes","volume":"11","author":"Roosen","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2540","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1212\/WNL.58.5.695","article-title":"Regional and progressive thinning of the cortical ribbon in Huntington\u2019s disease","volume":"58","author":"Rosas","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2545","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1205102109","article-title":"Progressive dopaminergic cell loss with unilateral-to-bilateral progression in a genetic model of Parkinson disease","volume":"109","author":"Rousseaux","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2550","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1750-3639.2012.00629.x","article-title":"Degeneration of the cerebellum in Huntingtons disease (HD): possible relevance for the clinical picture and potential gateway to pathological mechanisms of the disease process","volume":"23","author":"R\u00fcb","year":"2013","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2555","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/bpa.12115","article-title":"Huntington\u2019s disease (HD): degeneration of select nuclei, widespread occurrence of neuronal nuclear and axonal inclusions in the Brainstem","volume":"24","author":"R\u00fcb","year":"2014","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2560","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2119\/2003-00044.Herrera","article-title":"Attenuated hippocampus-dependent learning and memory decline in transgenic TgAPPswe Fischer-344 rats","volume":"10","author":"Ruiz-Opazo","year":"2004","journal-title":"Mol. Med."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2565","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2021.110368","article-title":"Nano-ivabradine averts behavioral anomalies in Huntington\u2019s disease rat modelvia modulating Rhes\/m-tor pathway","volume":"111","author":"Saad","year":"2021","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2570","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/jnen\/63.5.418","article-title":"Amyloid-\u03b2 deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP\/PS1 mice","volume":"63","author":"Sadowski","year":"2004","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2575","first-page":"1","article-title":"Naringenin mitigates behavioral alterations and provides neuroprotection against 3-nitropropinoic acid-induced Huntington\u2019s disease like symptoms in rats","volume":"15","author":"Salman","year":"2021","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2580","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/hmg\/8.5.813","article-title":"Formation of polyglutamine inclusions in non-CNS tissue","volume":"8","author":"Sathasivam","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2585","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","article-title":"Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions","volume":"95","author":"Saudou","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2590","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0306-4522(94)90605-X","article-title":"Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat","volume":"59","author":"Sauer","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2595","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0896-6273(04)00182-5","article-title":"Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration","volume":"42","author":"Saura","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2600","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41573-020-0065-9","article-title":"Leveraging preclinical models for the development of Alzheimer diseasetherapeutics","volume":"19","author":"Scearce-Levie","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2605","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2610","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1212\/01.wnl.0000260698.46517.8f","article-title":"Synaptic alterations in CA1 in mild alzheimer disease and mild cognitive impairment","volume":"68","author":"Scheff","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2615","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"Schilling","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2620","doi-asserted-by":"crossref","first-page":"8419","DOI":"10.1523\/JNEUROSCI.15-12-08419.1995","article-title":"Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo","volume":"15","author":"Schulz","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2625","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0028-3908(98)00204-4","article-title":"Mechanisms contributing to the deficits in hippocampal synaptic plasticity in mice lacking amyloid precursor protein","volume":"38","author":"Seabrook","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2630","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1001958023096","article-title":"MPTP susceptibility in the mouse: behavioral, neurochemical, and histological analysis of gender and strain differences","volume":"30","author":"Sedelis","year":"2000","journal-title":"Behav. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2635","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0166-4328(01)00309-6","article-title":"Behavioral phenotyping of the MPTP mouse model of Parkinson\u2019s disease","volume":"125","author":"Sedelis","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2640","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.fct.2018.05.022","article-title":"Topiramate mitigates 3-nitropropionic acid-induced striatal neurotoxicity via modulation of AMPA receptors","volume":"118","author":"Shalaby","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2645","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0278-5846(98)00070-0","article-title":"Comparison of intrastriatal injections of quinolinic acid and 3- nitropropionic acid for use in animal models of Huntington\u2019s disease","volume":"22","author":"Shear","year":"1998","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2650","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/hmg\/8.5.763","article-title":"A Huntington\u2019s disease CAG expansion at the murine hdh locus is unstable and associated with behavioural abnormalities in mice","volume":"8","author":"Shelbourne","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2655","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0092-8674(00)80244-5","article-title":"Skeletal and CNS defects in Presenilin-1-deficient mice","volume":"89","author":"Shen","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2660","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/exnr.2002.8072","article-title":"Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation","volume":"179","author":"Sherer","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2665","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","article-title":"Cloning of a gene bearing missense mutations in early-onset familial Alzheimer\u2019s disease","volume":"375","author":"Sherrington","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2670","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jneuroim.2015.12.003","article-title":"Role of Cox-2 mediated neuroinflammation on the neurodegeneration and cognitive impairments in colchicine induced rat model of Alzheimer\u2019s disease","volume":"291","author":"Sil","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2675","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s12031-016-0817-5","article-title":"Dual role of vitamin C on the neuroinflammation mediated neurodegeneration and memory impairments in colchicine induced rat model of alzheimer disease","volume":"60","author":"Sil","year":"2016","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2680","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nbd.2010.09.012","article-title":"Neurobiology of Disease Altered adult hippocampal neurogenesis in the YAC128 transgenic mouse model of Huntington disease","volume":"41","author":"Simpson","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2685","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7361613","article-title":"Overview of Alzheimer\u2019s disease and some therapeutic approaches targeting A\u03b2 by using several synthetic and herbal compounds","author":"Singh","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2690","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0306-4522(88)90223-0","article-title":"Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP into the nigrostriatae dopamine pathway\u2014I. Behavioural, neurochemical and histological characterization of the lesion","volume":"27","author":"Sirinathsinghji","year":"1988","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2695","doi-asserted-by":"crossref","first-page":"43030","DOI":"10.1038\/srep43030","article-title":"Metabolic profiling of presymptomatic Huntington\u2019s disease sheep reveals novel biomarkers","volume":"7","author":"Skene","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2700","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/hmg\/ddv628","article-title":"LRRK2 BAC transgenic rats develop progressive, L-DOPA-responsive motor impairment, and deficits in dopamine circuit function","volume":"25","author":"Sloan","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2705","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2710","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1073\/pnas.082107399","article-title":"Imaging the progression of alzheimer pathology through the brain","volume":"99","author":"Smith","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2715","doi-asserted-by":"crossref","first-page":"10893","DOI":"10.1073\/pnas.96.19.10893","article-title":"Age-associated neuronal atrophy occurs in the primate brain and is reversible by growth factor gene therapy","volume":"96","author":"Smith","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2720","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1471-4159.1977.tb03919.x","article-title":"Relation between physiological function and energy metabolism in the central nervous system","volume":"29","author":"Sokoloff","year":"1977","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2725","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/hmg\/dds397","article-title":"A fully humanized transgenic mouse model of Huntington disease","volume":"22","author":"Southwell","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2730","first-page":"1115","article-title":"A novel humanized mouse model of Huntington disease for preclinical development of therapeutics targeting mutant huntingtin alleles","volume":"26","author":"Southwell","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2735","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.neuroscience.2008.09.020","article-title":"Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington\u2019s disease","volume":"157","author":"Spampanato","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2740","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"\u03b1-Synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2745","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ymeth.2010.12.009","article-title":"Monitoring protein aggregation and toxicity in Alzheimer\u2019s disease mouse models using in vivo imaging","volume":"53","author":"Spires-Jones","year":"2011","journal-title":"Methods"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2750","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1126\/science.1896849","article-title":"The medial temporal lobe memory system downloaded from","volume":"253","author":"Squire","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2755","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/j.1471-4159.2006.04310.x","article-title":"Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigra","volume":"100","author":"St Martin","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2760","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/cne.20680","article-title":"Chronology of behavioral symptoms and neuropathological sequela in R6\/2 Huntington\u2019s disease transgenic mice","volume":"490","author":"Stack","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2765","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0002-9440(10)65423-5","article-title":"Association of microglia with amyloid plaques in brains of APP23 transgenic mice","volume":"154","author":"Stalder","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2770","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009399","article-title":"\u03b1-Synuclein in Parkinson\u2019s disease","volume":"2","author":"Stefanis","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2775","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1001\/archneur.65.7.906","article-title":"Distinct pools of \u03b2-Amyloid in alzheimer disease\u2013affected brain: a clinicopathologic study","volume":"65","author":"Steinerman","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2780","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1097\/00001756-199406020-00026","article-title":"Movement disorder following excitotoxin lesions in primates","volume":"5","author":"Storey","year":"1994","journal-title":"Neuroreport"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2785","doi-asserted-by":"crossref","first-page":"13287","DOI":"10.1073\/pnas.94.24.13287","article-title":"Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology","volume":"94","author":"Sturchler-Pierrat","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2790","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jstrokecerebrovasdis.2008.03.011","article-title":"Human apolipoprotein E4 targeted replacement mice show increased prevalence of intracerebral hemorrhage associated with vascular amyloid deposition","volume":"17","author":"Sullivan","year":"2008","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2795","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0006-8993(87)90986-3","article-title":"Studies on the effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in C57BL\/6 mice. Comparison with three other strains of mice","volume":"405","author":"Sundstr\u00f6m","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2800","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrn.2016.178","article-title":"Selective neuronal vulnerability in Parkinson disease","volume":"18","author":"Surmeier","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2805","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/jnc.13691","article-title":"The clinical symptoms of Parkinson\u2019s disease","volume":"139","author":"Sveinbjornsdottir","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2810","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0006-8993(87)90808-0","article-title":"Acetylcholinesterase fibers and the development of senile plaques","volume":"406","author":"Tago","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2815","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/810981","article-title":"Introducing human APOE into A\u03b2 transgenic mouse models","author":"Tai","year":"2011","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2820","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/mds.25669","article-title":"Neurophysiology of gait: from the spinal cord to the frontal lobe","volume":"28","author":"Takakusaki","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2825","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1083\/jcb.150.5.989","article-title":"Defects axonal elongation and neuronal migration in mice with disrupted tau and Map1b genes","volume":"150","author":"Takei","year":"2000","journal-title":"J. Cell J. Cell Biol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2830","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0165-3806(03)00056-7","article-title":"Isoforms changes of tau protein during development in various species","volume":"142","author":"Takuma","year":"2003","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2835","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1046\/j.1471-4159.2000.0752611.x","article-title":"In vivo labeling of mitochondrial complex I (NADH:ubiquinone oxidoreductase) in rat brain using [(3)H]dihydrorotenone","volume":"75","author":"Talpade","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2840","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12264-009-0324-6","article-title":"Observation of the density and size of cells in hippocampus and vascular lesion in thalamus of GFAP-apoE transgenic mice","volume":"25","author":"Tang","year":"2009","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2845","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/19338244.2018.1492894","article-title":"Paraquat exposure and Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"74","author":"Tangamornsuksan","year":"2019","journal-title":"Arch. Environ. Occup. Health"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2850","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2855","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2860","doi-asserted-by":"crossref","DOI":"10.3791\/3234","article-title":"Development of a unilaterally-lesioned 6-OHDA mouse model of Parkinson\u2019s disease","author":"Thiele","year":"2012","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2865","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1460-9568.2003.02781.x","article-title":"Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson\u2019s disease phenotype","volume":"18","author":"Thiruchelvam","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2870","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.0953-816X.2004.03139.x","article-title":"Risk factors for dopaminergic neuron loss in human alpha-synuclein transgenic mice","volume":"19","author":"Thiruchelvam","year":"2004","journal-title":"Eur. J. Neurosci."},{"issue":"4","key":"10.1016\/j.neubiorev.2022.104541_bib2875","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.0953-816X.2004.03139.x","article-title":"Risk factors for dopaminergic neuron loss in human alpha-synuclein transgenic mice","volume":"19","author":"Thiruchelvam","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2880","first-page":"169","volume":"13","author":"Thoenen","year":"1973"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2885","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009316","article-title":"A guide to neurotoxic animal models of Parkinson\u2019s disease","volume":"1","author":"Tieu","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2890","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1523\/JNEUROSCI.4965-05.2006","article-title":"Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for lewy body disorders","volume":"26","author":"Tofaris","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2895","doi-asserted-by":"crossref","first-page":"14622","DOI":"10.1073\/pnas.0906334106","article-title":"R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice","volume":"106","author":"Tong","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2900","doi-asserted-by":"crossref","first-page":"9879","DOI":"10.1073\/pnas.1004676107","article-title":"Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of \u03b1-synuclein, and apoptotic cell death in aged mice","volume":"107","author":"Tong","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2905","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/17460441.2018.1428556","article-title":"Novel models for Parkinson\u2019s disease and their impact on future drug discovery Novel models for Parkinson\u2019s disease and their impact on future drug discovery","volume":"13","author":"Trigo-Damas","year":"2018","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2910","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1097\/00001756-200412030-00020","article-title":"ApoE isoform affects LTP in human targeted replacement mice","volume":"15","author":"Trommer","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2915","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.nbd.2004.08.011","article-title":"ApoE isoform-specific effects on LTP: blockade by oligomeric amyloid-\u03b21\u201342","volume":"18","author":"Trommer","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2920","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0092-8674(00)81827-9","article-title":"The essential role of hippocampal CA1 NMDA receptor\u2013dependent synaptic plasticity in spatial memory","volume":"87","author":"Tsien","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2925","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.nbd.2014.08.027","article-title":"Conditional expression of Parkinson\u2019s disease-related R1441C LRRK2 in midbrain dopaminergic neurons of mice causes nuclear abnormalities without neurodegeneration","volume":"71","author":"Tsika","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2930","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/82868","article-title":"Neurotrophins are required for nerve growth during development","volume":"4","author":"Tucker","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2935","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2940","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(68)90164-7","article-title":"6-hydroxy-dopamine induced degeneration of central monoamine neurons","volume":"5","author":"Ungerstedt","year":"1968","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2945","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0006-8993(70)90187-3","article-title":"Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system","volume":"24","author":"Ungerstedt","year":"1970","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2950","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1002\/cne.24447","article-title":"A comparative study on pathological features of transgenic rat lines expressing either three or four repeat misfolded tau","volume":"526","author":"Valachova","year":"2018","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2955","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","article-title":"Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1","volume":"304","author":"Valente","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2022.104541_bib2960","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1046\/j.1460-9568.2003.02444.x","article-title":"Age-dependent cognitive decline in the APP23 model precedes amyloid deposition","volume":"17","author":"Van Dam","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2965","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/aje\/kwg068","article-title":"Incidence of Parkinson\u2019s disease: variation by age, gender, and race\/ethnicity","volume":"157","author":"Van Den Eeden","year":"2003","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2970","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2007.07.029","article-title":"Increased metabolism in the R6\/2 mouse model of Huntington\u2019s disease","volume":"29","author":"van der Burg","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2975","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1523\/JNEUROSCI.20-16-06021.2000","article-title":"Neuropathology in mice expressing human alpha-synuclein","volume":"20","author":"van der Putten","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2980","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.bbr.2006.10.024","article-title":"Impairments in spatial memory retention of GFAP-apoE4 female mice","volume":"176","author":"van Meer","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2985","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/hmg\/ddi147","article-title":"Loss of wild-type huntingtin influences motor dysfunction and survival in the YAC128 mouse model of Huntington disease","volume":"14","author":"Van Raamsdonk","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2990","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1093\/hmg\/ddl072","article-title":"Body weight is modulated by levels of full-length huntingtin","volume":"15","author":"Van Raamsdonk","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib2995","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.nbd.2007.01.006","article-title":"Testicular degeneration in Huntington disease","volume":"26","author":"Van Raamsdonk","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3000","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/NEN.0000000000000039","article-title":"Long-term overexpression of human wild-type and T240R mutant parkin in rat substantia nigra induces progressive dopaminergic neurodegeneration","volume":"73","author":"Van Rompuy","year":"2014","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3005","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105367","article-title":"Abnormal patterns of sleep and EEG power distribution during non-rapid eye movement sleep in the sheep model of Huntington\u2019s disease","volume":"155","author":"Vas","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3010","doi-asserted-by":"crossref","first-page":"78","DOI":"10.14283\/jpad.2019.3","article-title":"Editorial: implications for BACE1 inhibitor clinical trials: adult conditional BACE1 knockout mice exhibit axonal organization defects in the Hippocampus","volume":"6","author":"Vassar","year":"2019","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3015","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1006\/exnr.2002.7915","article-title":"Object recognition memory and cholinergic parameters in mice expressing human presenilin 1 transgenes","volume":"175","author":"Vaucher","year":"2002","journal-title":"Exp. Neurol."},{"issue":"Mar 1 (5)","key":"10.1016\/j.neubiorev.2022.104541_bib3020","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1523\/JNEUROSCI.20-05-01657.2000","article-title":"Neurons regulate extracellular levels of amyloid-protein via Proteolysis by insulin-degrading enzyme","author":"Vekrellis","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3025","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12775","article-title":"Acute tau knockdown in the Hippocampus of adult mice causes learning and memory deficits","volume":"17","author":"Velazquez","year":"2018","journal-title":"Aging Cell"},{"key":"10.1016\/j.neubiorev.2022.104541_bib3030","first-page":"244","article-title":"Endogenous dopamine enhances the neurotoxicity of 3-nitropropionic acid in the striatum through the increase of mitochondrial respiratory inhibition and free radicals production","volume":"29","author":"Villar\u00e1n","year":"2008","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neubiorev.2022.104541_bib3035","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bbr.2017.10.021","article-title":"Are rodent models of Parkinson\u2019s disease behaving as they should?","volume":"352","author":"Vingill","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3040","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00441-004-0924-4","article-title":"Parkin-associated Parkinson\u2019s disease","volume":"318","author":"von Coelln","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3045","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/hmg\/ddg075","article-title":"Transgenic rat model of Huntington\u2019s disease","volume":"12","author":"von Horsten","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3050","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0197-4580(97)00151-6","article-title":"Generation of APLP2 KO mice and early postnatal lethality in APLP2\/APP double KO mice","volume":"18","author":"von Koch","year":"1997","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2022.104541_bib3055","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington\u02bcs disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3060","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.neurobiolaging.2006.11.017","article-title":"Selective loss of nigral dopamine neurons induced by overexpression of truncated human \u03b1-synuclein in mice","volume":"29","author":"Wakamatsu","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2022.104541_bib3065","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3233\/JPD-140344","article-title":"Behavioral deficits and striatal DA signaling in LRRK2 p.G2019S transgenic rats: a multimodal investigation including PET neuroimaging","volume":"4","author":"Walker","year":"2014","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3070","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0006-8993(02)03137-2","article-title":"Olfactory identification and apolipoprotein e E4 allele in mild cognitive impairment","volume":"951","author":"Wang","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3075","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1523\/JNEUROSCI.4660-04.2005","article-title":"Defective neuromuscular synapses in mice lacking amyloid precursor protein (APP) and APP-like protein 2","volume":"25","author":"Wang","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3080","doi-asserted-by":"crossref","first-page":"8677","DOI":"10.1523\/JNEUROSCI.2440-08.2008","article-title":"BACE1 knock-outs display deficits in activity-dependent potentiation of synaptic transmission at mossy fiber to CA3 synapses in the Hippocampus","volume":"28","author":"Wang","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3085","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123431","article-title":"BACE2, a conditional \u03b2-Secretase, contributes to Alzheimer\u2019s disease pathogenesis","volume":"4","author":"Wang","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.neubiorev.2022.104541_bib3090","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1037\/1064-1297.15.4.309","article-title":"The value of nonhuman primates in drug abuse research","volume":"15","author":"Weerts","year":"2007","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3095","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/2051-5960-2-36","article-title":"Comparative analysis of single and combined APP\/APLP knockouts reveals reduced spine density in APP-KO mice that is prevented by APPs\u03b1 expression","volume":"2","author":"Weyer","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3233\/JHD-200426","article-title":"Modifiers of CAG\/CTG repeat instability: insights from mammalian models","volume":"10","author":"Wheeler","year":"2021","journal-title":"J. Huntingtons Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3105","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/hmg\/9.4.503","article-title":"Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in Hdh(Q92) and Hdh(Q111) knock-in mice","volume":"9","author":"Wheeler","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3110","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/hmg\/11.6.633","article-title":"Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice","volume":"11","author":"Wheeler","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3115","first-page":"1","article-title":"WHO methods and data sources for country-level causes of death 2000-2015","author":"WHO","year":"2017","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3120","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0002-9440(10)63419-0","article-title":"\u03b2-Site amyloid precursor protein cleaving enzyme 1 increases amyloid deposition in brain parenchyma but reduces cerebrovascular amyloid angiopathy in ging BACE \u00d7 APP[V717I] Double-Transgenic Mice","volume":"165","author":"Willem","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3125","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1126\/science.1132341","article-title":"Control of peripheral nerve myelination by the \u03b2-Secretase BACE1","volume":"314","author":"Willem","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2022.104541_bib3130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010195","article-title":"Characterization of age-dependent and progressive cortical neuronal degeneration in presenilin conditional mutant mice","volume":"5","author":"Wines-Samuelson","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2022.104541_bib3135","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.nbd.2010.12.008","article-title":"Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice","volume":"41","author":"Winner","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3140","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/387288a0","article-title":"Presenilin 1 is required for notch 1 and Dll1 expression in the paraxial mesoderm","volume":"387","author":"Wong","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2022.104541_bib3145","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.neurobiolaging.2007.09.003","article-title":"Dystrophic neurites in TgCRND8 and Tg2576 mice mimic human pathological brain aging","volume":"30","author":"Woodhouse","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2022.104541_bib3150","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.biopsych.2006.11.013","article-title":"A functional magnetic resonance imaging study of amygdala responses to human faces in aging and mild Alzheimer\u2019s disease","volume":"62","author":"Wright","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2022.104541_bib3155","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.ajhg.2019.04.007","article-title":"Length of uninterrupted CAG, independent of polyglutamine size, results in increased somatic instability, hastening onset of Huntington disease","volume":"104","author":"Wright","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3160","doi-asserted-by":"crossref","first-page":"15091","DOI":"10.1073\/pnas.1304171110","article-title":"Presenilins regulate calcium homeostasis and presynaptic function via ryanodine receptors in hippocampal neurons","volume":"110","author":"Wu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3165","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0163-7258(00)00081-4","article-title":"Animal models of Alzheimer\u2019s disease and evaluation of anti-dementia drugs","volume":"88","author":"Yamada","year":"2000","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3170","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1254\/jphs.91.267","article-title":"Brain-derived neurotrophic factor\/TrkB signaling in memory processes","volume":"91","author":"Yamada","year":"2003","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3175","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1471-4159.2004.02728.x","article-title":"Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson\u2019s disease","volume":"91","author":"Yamada","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3180","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0896-6273(93)90192-T","article-title":"Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids","volume":"11","author":"Yamagata","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2022.104541_bib3185","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1750-1326-2-10","article-title":"Absence of dopaminergic neuronal degeneration and oxidative damage in aged DJ-1-deficient mice","volume":"2","author":"Yamaguchi","year":"2007","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3190","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","article-title":"Reversal of neuropathology and motor dysfunction in a conditional model of Huntington\u2019s disease","volume":"101","author":"Yamamoto","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.neubiorev.2022.104541_bib3195","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40035-016-0061-5","article-title":"Stepping closer to treating Alzheimer\u2019s disease patients with BACE1 inhibitor drugs","volume":"5","author":"Yan","year":"2016","journal-title":"Transl. Neurodegener."},{"issue":"Mar (3)","key":"10.1016\/j.neubiorev.2022.104541_bib3200","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1474-4422(13)70276-X","article-title":"Targeting the \u03b2 secretase BACE1 for Alzheimer\u2019s disease therapy","volume":"13","author":"Yan","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3205","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.cell.2018.03.005","article-title":"A huntingtin knockin pig model recapitulates features of selective neurodegeneration in Huntington\u2019s disease","volume":"173","author":"Yan","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.neubiorev.2022.104541_bib3210","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1101\/gr.1984404","article-title":"Patterns of insertions and their covariation with substitutions in the rat, mouse, and human genomes","volume":"14","author":"Yang","year":"2004","journal-title":"Genome Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3215","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neulet.2005.04.040","article-title":"Reduced synaptic vesicle density and active zone size in mice lacking amyloid precursor protein (APP) and APP-like protein 2","volume":"384","author":"Yang","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3220","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nature06975","article-title":"Towards a transgenic model of Huntington\u2019s disease in a non- human primate","volume":"453","author":"Yang","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2022.104541_bib3225","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10571-008-9341-7","article-title":"Hyperphosphorylation and accumulation of neurofilament proteins in transgenic mice with Alzheimer presenilin 1 mutation","volume":"29","author":"Yang","year":"2009","journal-title":"Cell. Mol. Neurobiol."},{"issue":"Oct 15 (20)","key":"10.1016\/j.neubiorev.2022.104541_bib3230","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1093\/hmg\/ddq313","article-title":"Expression of Huntington\u2019s disease protein results in apoptotic neurons in the brains of cloned transgenic pigs","volume":"19","author":"Yang","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3235","doi-asserted-by":"crossref","first-page":"8345","DOI":"10.1523\/JNEUROSCI.0772-15.2015","article-title":"Mutant alpha-synuclein causes age-dependent neuropathology in Monkey Brain","volume":"35","author":"Yang","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3240","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/s41401-020-00558-4","article-title":"Ginsenoside Rg1 exerts neuroprotective effects in 3-nitropronpionic acid-induced mouse model of Huntington\u2019s disease via suppressing MAPKs and NF-kappaB pathways in the striatum","volume":"42","author":"Yang","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3245","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0304-3940(00)01675-X","article-title":"Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of \u03b2-amyloid peptide","volume":"297","author":"Yasojima","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3250","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.neurobiolaging.2012.06.016","article-title":"Detecting spatial memory deficits beyond blindness in Tg2576 alzheimer mice","volume":"34","author":"Yassine","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2022.104541_bib3255","doi-asserted-by":"crossref","first-page":"41774","DOI":"10.1074\/jbc.M112.407957","article-title":"APOE4-specific changes in a accumulation in a new transgenic mouse model of alzheimer disease","volume":"287","author":"Youmans","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3260","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0896-6273(01)00417-2","article-title":"APP processing and synaptic plasticity in presenilin-1 conditional knockout mice","volume":"31","author":"Yu","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2022.104541_bib3265","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1523\/JNEUROSCI.23-06-02193.2003","article-title":"Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington\u2019s disease","volume":"23","author":"Yu","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3270","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.nbd.2015.02.031","article-title":"Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice","volume":"78","author":"Yue","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3275","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","article-title":"Increased sensitivity to N-methyl-D-aspartate in a mouse model of Huntington\u2019s disease","volume":"33","author":"Zeron","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2022.104541_bib3280","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.brainres.2010.08.077","article-title":"An okadaic acid-induced model of tauopathy and cognitive deficiency","volume":"1359","author":"Zhang","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3285","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1411543","article-title":"Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E","volume":"258","author":"Zhang","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2022.104541_bib3290","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/nature08177","article-title":"Presenilins are essential for regulating neurotransmitter release","volume":"460","author":"Zhang","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2022.104541_bib3295","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/j.1471-4159.2010.07011.x","article-title":"Inactivation of presenilins causes pre-synaptic impairment prior to post-synaptic dysfunction","volume":"115","author":"Zhang","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3300","article-title":"Ameliorative effects of a combination of Baicalin, Jasminoidin and cholic acid on ibotenic acid-induced dementia model in rats","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2022.104541_bib3305","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.nbd.2007.08.014","article-title":"Impaired hippocampal neurogenesis is involved in cognitive dysfunction induced by thiamine deficiency at early pre-pathological lesion stage","volume":"29","author":"Zhao","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3310","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neurobiolaging.2016.02.011","article-title":"Sex differences in metabolic aging of the brain: insights into female susceptibility to Alzheimer\u2019s disease","volume":"42","author":"Zhao","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2022.104541_bib3315","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0092-8674(95)90073-X","article-title":"\u0392-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity","volume":"81","author":"Zheng","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.neubiorev.2022.104541_bib3320","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0006-8993(97)01533-3","article-title":"Apolipoprotein-e deficiency results in an altered stress responsiveness in addition to an impaired spatial memory in young mice","volume":"788","author":"Zhou","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3325","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1111\/j.1460-9568.2007.05812.x","article-title":"Non-motor behavioural impairments in parkin-deficient mice","volume":"26","author":"Zhu","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3330","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/j.febslet.2006.05.029","article-title":"Truncated tau from sporadic Alzheimer\u2019s disease suffices to drive neurofibrillary degeneration in vivo","volume":"580","author":"Zilka","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3335","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2022.104541_bib3340","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0006-8993(89)90163-7","article-title":"Complex responses activated by ibotenate in postnatal rat hippocampal neurons","volume":"494","author":"Zorumski","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2022.104541_bib3345","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington\u2019s disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2022.104541_bib3350","doi-asserted-by":"crossref","first-page":"13042","DOI":"10.1038\/ncomms13042","article-title":"Chemoproteomic profiling reveals that cathepsin d off-target activity drives ocular toxicity of \u03b2-secretase inhibitors","volume":"7","author":"Zuhl","year":"2016","journal-title":"Nat. Commun."}],"container-title":["Neuroscience &amp; Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763422000276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763422000276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:04:33Z","timestamp":1758967473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763422000276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":670,"alternative-id":["S0149763422000276"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2022.104541","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The three sisters of fate: Genetics, pathophysiology and outcomes of animal models of neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2022.104541","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104541"}}